An integrated modelling/experimental framework for protein-producing cell cutures by Kontoravdi, Cleo & Kontoravdi, Cleo
An Integrated Modelling/Experimental 
Framework for Protein-Producing Cell Cultures 
Cleo Kontoravdi 
June 2006 
A thesis submitted for the degree of Doctor of Philosophy of the University of London 
and for the Diploma of Membership of Imperial College London 
Centre for Process Systems Engineering, 
Department of Chemical Engineering and Chemical Technology, 
Imperial College London, United Kingdom 
Abstract 
Fed-batch animal cell cultures are the most commonly used method for producing mon-
oclonal antibodies in industry. Although most existing protocols have been developed 
based on empirical knowledge, there is scope for using model-based tools with the aim 
of further improving productivity and expediting process development. The efficacy of 
such approaches depends on the reliability of the mathematical representation developed. 
In this thesis, an integrated hybrid mathematical model of mammalian cell cultures that 
describes the most important cellular functions, namely cell metabolism, cell growth and 
death, and monoclonal antibody synthesis, glycosylation and production, is presented. Its 
novelty lies in the fact that it successfully couples cell metabolism with cell growth and 
antibody synthesis, while remaining computationally tractable. Model structure is first 
validated by comparison to batch cultures of an antibody-producing hybridoma cell line 
and initial estimates for model parameter values are obtained. 
The Sobol' method for global sensitivity analysis and qualitative one-at-a-time screen-
ing techniques are then used to identify the parameters that mostly influence the model 
outputs (experimentally measured variables). This reduces the set of parameters to be 
accurately estimated from experimental data from 30 to 7. Optimal experimental design is 
employed to extend the applicability of the model to fed-batch conditions. The generated 
information-rich data are used to estimate these parameters under fed-batch culture oper-
ation, resulting in good agreement between simulation results and experimental findings. 
Finally, the predictive capability of the model under fed-batch conditions is confirmed by 
successful comparison with arm independent set of data. This approach systematises the 
process of developing predictive cell culture models at a minimum experimental cost and 
paves the way for model-based control and optimisation applications. 
Abstract 	 ii 
To further extend the proposed model, an unstructured mathematical formulation de-
scribing cell growth and death kinetics and cell metabolism of glucose and 19 amino acids 
for mammalian cell cultures is developed. Amino acids are necessary for both protein 
synthesis and as an energy source. The proposed mathematical framework is in good 
agreement with experimental data from batch cultures of human embryonic kidney 293 
cell cultures and is also applicable (with minor modifications) to cultures of interferon-y-
producing Chinese hamster ovary cells. The model further accommodates the inclusion 
of expressions for other cellular activities, such as the production of recombinant viral 
vectors or proteins, and can be used as a basis for the development of a model library for 
animal cell cultures. 
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Chapter 1 
Introduction 
Biologics represent a new class of diagnostic and therapeutic agents derived from living 
cells. Products include vaccines, hormones, enzymes, and monoclonal antibodies (MAbs), 
the latter being the fastest growing agent. The market of MAbs is expected to rise at an av-
erage annual growth rate of 11.5% to nearly $26 billion in 2010 (www.drugresearcher.com). 
Commercial production of MAbs is based on in vitro cultivation of mammalian cells, with 
industrial operation of these culture systems being mainly based on empirical knowledge 
(Bibila and Robinson, 1995; Dhir et al., 2000). Despite the advantages of model-based ap-
plications widely used in the chemical, petrochemical and, more recently, pharmaceutical 
industries, the biopharmaceutical industry has yet to benefit from systematic engineering 
approaches. 
Mathematical models of protein-secreting cell cultures can be used for in silico exper-
imentation in an effort to reduce expenditure on unnecessary laboratory experiments and 
to facilitate our understanding of the underlying biology (Bailey, 1998). They can further 
help organise the disparate information that is increasingly generated, for example, by the 
genomic and proteomic technologies (Bailey, 1998; Schilling et al., 1999; Hatzimanikatis 
et al., 1999a). Finally, models can provide the basis for optimisation and control studies 
with the aim of improving MAb production levels and meeting market demand (Bibila 
and Robinson, 1995).One such example is the work of Xie and Wang (1994), in which a 
stoichiometric model on energy metabolism for animal eel culture was used for medium 
design, as well as to develop a control strategy for fed-batch cultuvation. The result was 
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a significant reduction in the accumulation of toxic metabolites, which led to a 1.6-fold 
increase in antibody concentration compared to the generic fed-batch process. There are 
two broad categories of cell culture models: structured and unstructured. Structured 
models take into account the inner structure of the cells, whereas unstructured models 
only consider changes in the extracellular environment (Tziampazis and Sambanis, 1994). 
Even though structured models constitute a more detailed and biologically consistent rep-
resentation of cellular activities, they examine single cells and fail to describe the collective 
behaviour of the entire population. Attempts to overcome this limitation, including the 
combination of such single-cell models with population balance equations (Sidoli et al., In 
press) or the simulation of a large number of single-cell models with different initial condi-
tions (Domach and Shuler, 1984), pose significant computation and validation challenges 
that render them unsuitable for further applications. 
Unstructured models, on the other hand, provide a useful alternative when the underly-
ing biological mechanisms are not well understood or when aiming to develop model-based 
applications (Dowd et al., 1999; Dhir et al., 2000). Their main advantages include that 
they involve extracellular culture variables that are typically monitored during a culture, 
as well as that their simulation and subsequent in silico applications are computation-
ally tractable. One of the major problems associated with unstructured models though 
is their limited range of applicability, since they are usually validated with experimental 
data from batch cultures, even though fed-batch cultures are known to increase levels 
of protein production and are preferred industrially (Bibila and Robinson, 1995). It is 
therefore desirable to develop a systematic framework that creates predictive, unstruc-
tured or hybrid, tractable models of cell culture processes under fed-batch conditions. In 
the past, most studies involving mathematical models were carried out once experiments 
had already been performed. Nevertheless, this approach does not guarantee that the 
experimental data collected will be sufficient for model validation and parameter estima-
tion purposes (Versyck et al., 1997; Nathanson and Saidel, 1985). Issues arising include 
inadequate number of culture samples or data from uninformative culture times when few 
changes are taking place. 
The research aim of this thesis is the construction of a systematic framework for the 
development of predictive mathematical models of protein-producing cell cultures and its 
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Figure 1.1: Proposed framework for model development in animal cell culture systems. 
validation under batch and fed-batch process conditions (figure 1.1). The strategy is to 
create a simple model structure following a mainly reductionistic approach, in an effort 
to maintain computational tractability of the model itself and of subsequent model-based 
applications. Model development is, therefore, based on the inclusion of process variables 
that can be monitored experimentally in our laboratory. The model-based techniques of 
parameter sensitivity analysis and optimal experimental design are employed for model 
validation and parameter estimation purposes in order to avoid unnecessary or uninfor-
mative experimentation. Overall, the goal is to close the loop between the model and 
the experimental set-up and to create a reliable in silico environment that will expedite 
process development in this field. 
The structure of this thesis is as follows. First, an overview of the biological principles 
underlying the system studied is presented in chapter 2. This is followed by a review of 
experimental findings from the literature and a critical comparison of the most important 
modelling approaches of cell culture processes. The hybrid model of antibody-producing 
hybridoma cell cultures developed based on the relevant literature is presented in chapter 
3. The model involves expressions for cell growth and death, metabolism of glucose and 
glutamine with the resulting generation of lactate and ammonia, and intracellular syn-
thesis and production of monoclonal antibodies (MAbs). Suitable model analysis tools, 
namely parameter sensitivity analysis and optimal experimental design methods, are then 
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critically reviewed, followed by an outline of experimental techniques and protocols used. 
In chapter 4, the structure of the proposed model is validated through comparison with 
experimental data from batch cultures of a HFN 7.1 hybridoma cell line producing MAbs 
(IgG1) against fibronectin from human plasma. The generated data are also used to pro-
vide initial estimates for model parameters. Following that, the Sobol' method for global 
sensitivity analysis is used to identify the most sensitive model parameters with respect 
to extracellular MAb concentration, as discussed in chapter 5. The dynamic behaviour 
of the results and the effect of first-order interactions between model parameters are also 
analysed. 
A further qualitative one-at-a-time screening is performed to determine which para-
meters mostly influence the remaining measured variables, namely glucose, glutamine, 
lactate, and ammonia concentrations, as well as viable and total cell concentrations, as 
discussed in chapter 6. The accurate estimation of these parameters is then targeted 
through D-optimal model-based experimental design. The latter dictates the appropriate 
feeding strategy for a fed-batch experiment so that the information content of the collected 
data is maximized. The data of the designed culture are used to validate the model under 
fed-batch conditions. Its predictive capability is checked against data from an indepen-
dent set of fed-batch experiments. A further study on amino acid metabolism is presented 
in chapter 7, involving the development of an unstructured mathematical model for cell 
population kinetics and cell metabolism of the human embryonic kidney 293 cell line. The 
model is constructed based on published information and empirical knowledge, and its 
simulation results are compared with data from batch cultures of the cell line. Finally, 
chapter 8 outlines the main findings and contributions of this work, and makes suggestions 
for future research directions in this field. 
Chapter 2 
Literature Review 
2.1 Fundamentals of Cell Biology 
2.1.1 Mammalian Cells 
Cell Structure 
Mammalian cells have the typical structure of eukaryotic cells (Fig. 2.1). Their most 
important organelle is the nucleus, which contains the DNA that is organised into separate 
chromosomes. The nucleus occupies 10% of the total cell volume and is enclosed within 
the nuclear envelope, which is directly connected to the endoplasmic reticulum (ER). The 
ER is part of a continuous single-membrane system that is found throughout the cell. It 
is also attached to the cell membrane and constitutes more than 50% of the total cell 
membrane. The ER occurs in two forms: the rough ER, to which ribosomes are bound, 
and the smooth ER. Its function is to provide the millions of ribosomes that exist in a 
typical eukaryotic cell with adequate surface area for the synthesis of proteins (Alberts 
et al., 2002). 
Another important organelle is the Golgi apparatus. It is a collection of flattened 
membrane-bound vesicles or sacs that is separate from the ER but is frequently found 
close to it. This organelle is the site where sugars are linked to other cellular components, 
i.e.. the site of protein and lipid glycosylation (Alberts et al., 2002). The cell contains 
several other organelles, such as the mitochondria, which are not examined here as they 
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Figure 2.1: Structure of a typical mammalian cell (micro.magnet.fsu.edu). 
are not included in the proposed model. 
Cell Metabolism 
Two coupled streams of chemical reactions occur in the cells: 
1. The catabolic breakdown (oxidation) of food molecules, which generates energy in 
the form of adenosine triphosphate (ATP) and some of the small molecules that the 
cell needs as building blocks, and 
2. The anabolic, or biosynthetic, pathways (reduction), which use the energy produced 
during catabolism to synthesise other molecules that form the cell. 
Together, these two sets of reactions, which constitute separate and not simply reverse 
pathways, are known as the cell metabolism. Metabolism occurs in stages ensuring the 
efficient production and use of energy (Alberts et al., 2002). 
The chemical reactions that a cell normally carries out take place with the help of 
specialised proteins called enzymes, each of which catalyses just one of the many possible 
kinds of reactions that a particular molecule might undergo. These enzymes also act as 
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regulators, controlling the overproduction of molecules in metabolic pathways, but also 
speeding up production if needed. In this way, they help maintain the homeostasis of 
the cell, i.e., the balance of its biological activities (Alberts et al., 2002). Homeostasis is 
particularly evident during times of starvation, when compounds that are usually combined 
to form the structural components of the cell, namely proteins, are also used to produce 
energy. Deprivation of nutrients can generally alter the metabolic pathways undertaken by 
the cell, therefore leading to different nutrient utilisation, as well as energy production and 
requirements (Europa et al., 2000; Doverskog et al., 1997). The major nutrients are glucose 
and amino acids, the most important of which is glutamine (Telling and Radlett, 1970; 
Hauser and Wagner, 1997). The oxidation of these compounds gives rise to two primary 
metabolites: lactate and ammonia. There are three main sets of metabolic reactions: 
glycolysis in the cytosol, the citric acid cycle in the mitochondrial matrix, and oxidative 
phosphorylation on the inner mitochondrial membrane (Alberts et al., 2002). 
Cell cycle 
The most basic functions of the cell cycle are to accurately duplicate the DNA and then 
precisely segregate the copies into the two genetically identical daughter cells. These 
processes define the two major phases, S (for synthesis) and M (for mitosis) and the two 
gap phases, G1 and G2, of the cell cycle (Alberts et al., 2002). Their time sequence is G1 , 
S, G2, and M (see figure 2.2). The G1 phase of the cell cycle is a period during which 
the cell performs its physiological cellular activities. Its duration depends on external 
conditions and signals from other cells. If the extracellular conditions are unfavourable, 
cells delay progress through G1 and may even enter the Go resting state (part of the G1  
phase), in which they can remain for days, weeks or even years, before they either resume 
proliferation or undergo programmed cell death. For proliferating cells, the G1 phase lasts 
approximately 9 hours (Alberts et al., 2002). 
During the S phase, DNA duplication occurs. This process requires 10-12 hours and 
occupies almost half of the cell cycle time in a typical mammalian cell. G2 is a short (4.5 
hours) gap phase between the S and M phases, in which the cell prepares for division. 
G1, S, and G2 together are called the interphase. The cell cycle is completed by the 
M phase , which requires less than an hour in mammalian cells. During this phase the 
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Figure 2.2: The cell cycle (www.med.unibs.it). 
nuclear envelope breaks down, the sister chromatids are separated and two identical cells 
are formed each consisting of one set of the replicated chromosomes (Alberts et al., 2002). 
Cell Death 
As mentioned above, at some point in their lifetime and while in the G1  (or Go) phase, cells 
undergo programmed cell death. Also known as apoptosis, programmed cell death is a 
genetically controlled death process where the fate of the cell is determined by the relative 
abundance of survival and death factors and has four phases: initiation, signalling, effector 
and degradation. Apoptosis is generally characterised by cell shrinkage, loss of sphericity, 
swollen endoplasmic reticulum and Golgi apparatus, chromatin condensation and specific 
DNA degradation (Alberts et al., 2002). The three main factors that can trigger apoptosis 
have been reported to be nutrient exhaustion, accumulation of toxic metabolites (such as 
lactate and ammonia), and accumulation of an autocrine macromolecular inducer (Franek 
and Sramkova, 1996). Furthermore, it can be brought on by the application of severe 
mechanical stress on the cells (e.g. by moving mechanical parts of the culture vessel). 
Apoptosis can be prevented by the presence of protective factors (e.g. serum), measured 
availability, but not excess or total absence, of essential nutrients, overexpression of anti-
death genes such as bcl-2, and a slow cell cycle rate (Sanfeliu and Stephanopoulos, 1999). 
Violent changes in the cell's environment can cause a degenerate form of death called 
necrosis. What follows cell death is a process termed lysis, during which the dead cell's 
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Figure 2.3: An overview of protein synthesis (www.accessexcellence.org). 
membrane breaks resulting in disintegration (Alberts et al., 2002). 
2.1.2 Protein Synthesis 
A protein molecule consists of a long chain of amino acids linked together through a 
covalent peptide bond. There are 20 types of amino acids that participate in protein 
synthesis, each with different chemical properties. Before a protein can be synthesised, the 
corresponding messenger RNA (mRNA) molecule must be produced through the process 
of transcription from the DNA gene that codes for that specific protein (Fig. 2.3). The 
information about the amino acid sequence of the protein is carried by both DNA and 
mRNA in the form of nucleotide bases, namely adenine (A), guanine (G), cytosine (C), 
and thymine (T) in DNA (or uracil (U) in RNA). These four bases form complementary 
pairs: guanine with cytosine and adenine with thymine (in DNA) or uracil (in RNA) 
(Alberts et al., 2002). 
mRNA is the carrier of genetic information from the nucleus to the site of protein 
synthesis, the ribosomes, where it is translated. The ribosomes consist of more than 50 
different proteins and several RNA molecules, the ribosomal RNAs (rRNAs). Each triplet 
of consecutive bases in the mRNA sequence is called a codon and corresponds to a specific 
amino acid. However, the codons in an mRNA molecule do not directly recognise the 
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amino acids they specify. The translation of mRNA into protein is carried out by a set of 
small RNA molecules known as transfer RNAs (tRNAs). These molecules contain a region 
that forms the anticodon, a set of three consecutive nucleotides that is complementary to 
the codon in the mRNA molecule, thus creating the amino acid sequence that forms the 
protein. Some proteins are synthesised at fixed rates throughout the lifetime of the cell 
(housekeeping), while for others production is initiated by external signals, as is the case 
for in vivo monoclonal antibody production. In the latter case, production rates can differ 
significantly with time and position in the cell cycle (Alberts et al., 2002). 
Monoclonal Antibodies 
Antibodies are proteins produced by B lymphocytes, the only cells capable of specifically 
recognising and distinguishing antigenic epitopes as part of an organism's immune re-
sponse. Their role is to recognise a single type of antigenic site, bind to it and in this 
way deactivate it. They also recruit various types of white blood cells to kill the invading 
pathogens. In mammals, there are five classes of antibodies, IgA, IgD, IgE, IgG and IgM, 
each with its own class of heavy chain, a, 6, F , -y, and µ, respectively, with IgG being the 
major class of immunoglobulin in blood (Alberts et al., 2002). 
Antibodies are Y-shaped (Fig. 2.4) with two identical antigen-binding sites, one at 
the tip of each arm of the Y, and consist of four polypeptide chains: two identical light 
(L) chains, each containing about 220 amino acids, and two identical heavy (H) chains, 
each containing about 440 amino acids. Light chains have a constant sequence of approxi-
mately 110 amino acids (constant region) and a variable region of the same size. The heavy 
chains' constant and variable regions are 330 to 440 amino acids and 110 amino acids long, 
respectively. It is the variable regions of the heavy and light chains that come together 
to form the antigen-binding sites. The diversity of these regions is primarily restricted 
to three hypervariable regions in each chain, while the remaining parts are relatively con-
stant. Each antibody is responsible for the deactivation of a specific virus or microbial 
toxin, while antibodies synthesised by the same B cell have the same antigen-binding site 
(Alberts et al., 2002). 
However, antibodies are secreted by B lymphocytes, cells that have a limited life-span 
in vitro. This would normally constitute a great impediment for industrial production 
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Figure 2.4: An antibody molecule (www.accessexcellence.org). 
of antibodies, but has been overcome by the "immortalisation" of these cells. In this 
process a B lymphocyte from an immunised mouse or rat is fused with cells derived from 
an "immortal" B lymphocyte tumour, thereby creating a hybridoma cell (Kohler and 
Milstein, 1975). These hybrid cells are a permanent and stable source of antibodies with 
a single specificity, known as monoclonal antibodies. 
Protein glycosylation 
Glycosylation is the principal post-translational chemical modification of most proteins. 
It consists of the covalent addition and subsequent processing of sugars (oligosaccharides) 
on the proteins. The process begins with the en bloc addition of a preformed precursor 
oligosaccharide to the protein in the ER. This precursor is composed of N—acetylglucosamine, 
mannose, and glucose and contains a total of 14 sugars. These are then trimmed while the 
protein is still travelling through the ER, while further modifications and additions occur 
in the Golgi apparatus (Alberts et al., 2002). 
There are two possible structures of a glycosylated protein. The first one is when 
N—acetylglucosamine binds with amide groups (asparagine) and is called N—linked glyco-
sylation (Fig. 2.5). The second one (Fig. 2.6) occurs when N—acetylgalactosamine binds 
with hydroxyl groups of the protein (serine, threonine, or hydroxylysine), in which case 
it is called 0—linked glycosylation (Alberts et al., 2002). The mechanism of the latter 
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is not yet fully understood and, to my knowledge, has never been reported for human 
or murine immunoglobulin -y1 (IgG1) and is extremely rare for other human or murine 
immunoglobulin subclasses (Kunkel et al., 1998). It is, therefore, not considered further 
in this thesis. 
Kunkel et al. (1998) reported that IgG molecules from a variety of mammalian cells 
contain 2-3% carbohydrate by mass, without specifying the oligosaccharide distribution. 
Nevertheless, they do state that the oligosaccharides are mainly branched N-linked. Ac-
cording to the same study, IgG has been found to contain 2.3 N-linked oligosaccharide 
chains per molecule in mice and 2.8 in humans. Two of these are linked to the conserved 
glycosylation sites on the constant region of the antibody, whereas the remainder are found 
in the hypervariable regions, with a frequency and position dependent on the chance oc-
curence of the N-glycosylation consensus sequence (Asn-Xaa-Ser/Thr). 
N—glycosylation of secreted proteins can be affected by changes in the physicochemical 
environment of cells. In particular, decreased glucose concentration has been associated 
with decreased glycosylation of light chains. Another parameter that affects IgG glycosyla-
tion is the concentration of dissolved oxygen (DO) in the cell culture (Kunkel et al., 1998). 
A decrease in galactosylation has been observed at 10% DO as compared to 50 and 100% 
DO, even though the mechanism by which low DO results in decreased galactosylation of 
the MAb is unclear. The effect of DO concentration on production and glycosylation is 
not considered here as this is assumed to be controlled at the desired level during experi-
mentation. 
Changes in IgG glycosylation are generally confined to the constant region and there-
fore do not usually affect antigen binding. Nevertheless, they do affect the structural 
integrity of the antibody, and consequential susceptibility to proteolytic degradation, clear-
ance rate, antibody-dependent cellular toxicity, monocyte binding, and Fc receptor bind-
ing (Jefferis and Lund, 2002). Variable region glycosylation is also possible although it 
occurs much less frequently. The added sugars also appear to aid protein folding and 
the transport process. Furthermore, alterations in the glycosylation pattern of an anti-
body, for example through changes in glucose availability, have been shown to affect the 
antigen-binding activity of the antibody (Tachibana et al., 1994). There are also reports 
that N—linked glycosylation is essential for the expression of the biological activities of 
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Figure 2.6: 0-linked glycosylation (www.ionsource.com). 
therapeutic antibody drugs and that their efficacy varies with the precise structure of the 
oligosaccharides attached (Jefferis and Lund, 2002; Parekh et al., 1988). Monitoring MAb 
glycosylation is therefore an essential part of the production process. 
2.2 Cell Culture Processes and Models 
2.2.1 Cell Cultures 
Cell culture processes are largely classified into batch and continuous types. In batch cul-
tures, as time passes and the cells proliferate nutrients are consumed and toxic metabolites 
accumulate. Due to these events, cell growth is limited by lack of nutrients, but also inhib-
ited by the presence of metabolites, hence resulting in lower cell densities. This problem, 
associated with the nature of the culture, can be partly overcome by using fed-batch condi-
tions, where the necessary nutrients are added to the culture medium. Nevertheless, as the 
medium is not taken out of the system, a gradual build-up of metabolites is unavoidable. 
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Overall, fed-batch cultures are characterised by prolonged culture periods and higher cell 
densities in comparison to batch cultures, but require close monitoring. 
On the other hand, continuous cultures include chemostat and perfusion systems. In 
the former, fresh medium is continuously supplied to the bioreactor at the same rate as 
medium is taken out, therefore operating at steady state. The feed rate is such that the 
amount of proliferating cells is equal to that of cells leaving the reactor. Even though 
prolonged culture times can be achieved, cell density remains low due to cell removal 
through the outlet stream. In perfusion cultures, fresh medium is continuously fed into 
the bioreactor, while cell-free supernatant is taken out at the same rate. This process can 
provide higher cell densities, but requires optimal control of both culture conditions and 
supernatant removal, which makes its operation rather complicated (Hauser and Wagner, 
1997). 
There are several mammalian systems capable of high-level production of recombinant 
proteins for diagnostic and therapeutic applications. The most commonly used cell lines 
are Chinese hamster ovaries (CHO) cells, baby hamster kidney (BHK) cells, human embry-
onic kidney 293 (HEK-293) cells, lymphoma cell lines such as NSO, SP2, and YB2/0, and 
certain high-producing hybridoma cell lines (Ozturk and Hu, 2006; Hauser and Wagner, 
1997). Any cell line can be used for commercial manufacturing provided that it: 
1. supports high-level product expression over many months in culture, 
2. can be scaled-up to large volumes (100-10,0004 
3. can reach and maintain high viable cell density (> 5 x 10 6cells/mL in batch culture, 
> 10 8cells/mL in perfusion), 
4. performs appropriate post-translational protein modification, and 
5. can be appropriately characterised to assure freedom of the cell substrate from ad-
ventitious agents, especially viruses (Ozturk and Hu, 2006). 
This work focuses on hybridoma cells producing IgGl, the selection of which was based 
on the wide commercial availability of the cell line and the general applicability of the 
proposed mathematical model. However, the study of amino acid metabolism (see Chapter 
7) is based on the HEK-293 and CHO cell lines. 
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Figure 2.7: Model classification for prokaryotic and eukaryotic cell culture systems 
(adapted from Ramkrishna (1979)). 
2.2.2 Modelling Approaches 
In cell culture modelling there are three main distinctions (figure 2.7): unstructured ver-
sus structured, unsegregated (or distributed) versus segregated and deterministic versus 
stochastic (or probabilistic). 
Unstructured models do riot take into account the inner structure of the cell. Struc-
tured models, on the other hand, incorporate biological knowledge by lumping the bioma-
terial into distinct compartments, therefore providing a superior measure of the quality of 
the cell population. Unsegregated models regard the cell population as having an iden-
tical 'average' behaviour, while segregated models consider the differences within a cell 
population. The latter use the heterogeneity of the cells to relate different properties with 
distinct parts of the population. For mammalian cells, such models can be based, for 
example, on the cell cycle and the different characteristics attributed to the cells in each 
of its phases (Tziampazis and Sambanis, 1994). 
Finally, stochastic models vary from deterministic ones in that they use probability 
functions to describe process dynamics at the cell and population levels. They are more 
accurate than deterministic models as they account for randomness. Overall, it is clear 
that structured, segregated and stochastic models can theoretically represent cell cultures 
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in a more complete and accurate fashion, but are usually complex and highly computa-
tionally demanding. 
There are a number of well-established approaches to modelling cell cultures, each with 
its advantages and drawbacks. Firstly, kinetic single cell models (SCMs) describe in 
detail the metabolism of a single cell (Wu et al., 1992; Sanderson, 1997). For the purpose 
of modelling, cellular metabolism can be broken down into several processes such as mem-
brane and intracellular transport, product synthesis, and cell growth and death. There 
may, however, be sections of the model which are not based on biological knowledge but 
are mathematically inferred from experimental observations. SCMs usually only describe 
steady-state conditions; the development of dynamic SCMs is more complex due to the 
difficulty of determining intracellular reaction rates (Henson et al., 2002). Overall, the 
applications of SCMs have so far been limited since they only describe an average cell in 
the culture. 
In order to capture the heterogeneity of a cell population, Shuler and co-workers have 
developed cell ensemble models (Domach and Shuler, 1984). In this approach, a cluster 
of SCMs, which differ according to key properties, is solved in parallel to describe the 
cell population. Apart from ensembles used to predict steady-state and transient size 
distributions for E. coli cultures (Domach and Shuler, 1984; Ataai and Shuler, 1985), 
there have been hardly any recent developments or applications of this method (Henson 
et al., 2002) mainly due to limitations in computational power. 
An alternative for modelling cell cultures is based on the population balance equation 
(Fredrickson et al., 1967; Mantzaris et al., 1999). The resulting population balance 
models (PBMs) describe the cell number distribution as a function of time using one or 
more properties, such as cell age or cell mass, to distinguish between cells. PBMs can 
be classified as single- or multi-variable, single- or multi-staged, and mass or age struc-
tured (Mantzaris et al., 2001). A multi-variable PBM uses more than one cell property to 
distinguish between cells. A multi-staged PBM is used to describe more than one develop-
ment phases, each additional phase requiring an extra stage and therefore an extra single 
population balance equation. Finally, mass-structured PBMs employ mass, or any prop-
erty adhering to mass conservation, to differentiate between cells, whereas age-structured 
PBMs use cell maturity (Sidoli et al., 2004). 
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The use of PBMs is currently limited by computer power and by the difficulties as-
sociated with model parameter estimation. Even though flow cytometry data are slowly 
becoming available providing information on population distribution over the cell cycle 
phases, the lack of complete sets of data from mammalian expression systems is hindering 
the validation of PBMs. Moreover, these models offer no insight into cell metabolism 
and could not serve as process models in their current form. For this reason, investiga-
tors have started combining PBMs with other unstructured or single-cell models (Martens 
et al., 1995; Cain and Chau, 1998). Sidoli et al. (In press) recently presented a model 
that couples a highly metabolically structured SCM to a multi-staged mass-structured 
PBM. This paves the way for integrating information at both the population and the 
single-cell levels in an effort to increase model reliability. Nevertheless, due to its highly 
parameterised nature it is subject to computational limitations and validation difficulties. 
Even though it is a promising approach, the combination of SCMs and PBMs needs to 
be complemented with a thorough experimental study before it can prove its predictive 
capabilities. 
Another widely used approach is that of stoichiometric modelling (Follstad et al., 
1999; Paredes et al., 1999). Whereas kinetic models simulate dynamics, stoichiometric 
models tend to be solved for static conditions. The advantage is that metabolic networks 
can be represented exhaustively with little additional computational load. The chemical 
reactions and pathways that make up the metabolic network of the cell can be written as 
a set of dynamic flux balances. Since the time constants associated with growth are much 
larger than those associated with individual reactions, the steady-state approximation is 
used. Furthermore an additional assumption is made about the objective of cell behav-
iour, e.g. to maximise growth or minimise nutrient consumption (Schilling et al., 1999). 
This is then formulated into a mathematical objective function that can form part of an 
optimisation problem. However, this approach does not deal with the dynamics of cell 
behaviour, which is arguably of critical importance. 
Cybernetic models of single cells are based on the hypothesis that a cell's behaviour 
is steered by its desire to allocate resources in an optimal way (Ramkrishna, 1982). Regu-
latory or cybernetic variables act as controllers of resource allocation for enzyme synthesis 
and substrate suitability for growth. Detailed biochemical kinetics are used to characterise 
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the rates of synthesis of enzymes and components of biomass. Again, these are models 
of single cells that do not capture the dynamics of the entire culture population. Finally, 
there is the approach of unstructured modelling that uses empirical kinetic expressions 
along with mass balances for each of the components of interest. Even though such models 
incorporate minimal biological information, they are computationally tractable and easier 
to validate as they are based on commonly monitored process variables. Despite concerns 
about their range of validity, there are reports that unstructured models have been suc-
cessfully used for process control and optimisation purposes (Dowd et al., 1999; Zhang 
et al., 2004; de Tremblay et al., 1992; Iyer et al., 1999). 
2.2.3 Overview of published experimental findings and mathematical 
models 
In this review of the literature, only the relevant modelling approaches will be exam-
ined for each topic, following the research strategy outlined in Chapter 1. Regarding cell 
metabolism and cell growth and death, solely unstructured modelling attempts will be 
investigated; in terms of antibody synthesis and glycosylation, intracellular and compart-
mental models will be reviewed, respectively. 
Cell Metabolism 
Cell metabolism is concerned with nutrient consumption and metabolite formation through 
the several metabolic pathways of the cell. Nevertheless, as metabolism provides both the 
energy and the building blocks that are necessary for the survival and the progress of the 
cell through the cell cycle, cell growth and death are closely related to it and will also be 
examined in this section. 
Nutrients and Metabolites In the area of cell metabolism, most mathematical mod-
els examine glucose and glutamine as the primary nutrients and lactate and ammonia as 
the main metabolites. Apart from glutamine, several studies have been carried out on the 
metabolism of other amino acids, without there being an accurate mathematical model 
describing their consumption/production. A typical layout of an unstructured model for 
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cell metabolism consists of mass balances on glucose, glutamine, ammonia and lactate 
around the bioreactor. These account for the uptake of glucose and glutamine from viable 
cells for cell growth, as well as glucose consumption by glucokinase, glucose maintenance 
energy and spontaneous degradation of glutamine in the medium. Lactate and ammonia 
production are described as functions of glucose and glutamine consumption, respectively 
Pang and Barford, 2000). Monod-type kinetics are used for most metabolic models (Jang 
and Barford, 2000; Tziampazis and Sambanis, 1994; Tatiraju et al., 1999). 
It is important to note that lactate and ammonia are undesired by-products of cell 
metabolism. Lactate accumulation, which is primarily due to the incomplete oxidation 
of glucose via the glycolytic pathway (Schneider et al., 1996), lowers the pH of the cul-
ture medium, which, in turn, negatively affects cell growth and MAb production. While 
the optimum pH for cell growth and viability has been reported to lie in the 7.1 to 7.4 
range, lactate formation can reduce it to below 6.8 if an appropriate control scheme is not 
implemented, thus slowing down cell growth (Cherlet and Marc, 1998). Ammonia, the 
production of which appears to be inhibited by lactate formation (Gaertner and Dhurjati, 
1993), is often considered by researchers to be one of the main causes of cell death, which 
is depicted in the relevant mathematical models. 
Mammalian cells are capable of utilising varying proportions of glucose and glutamine 
and metabolising them differently under varying chemical environments. This ability gives 
rise to a multiplicity of metabolic steady states (Europa et al., 2000), which can be very 
difficult to model, especially since it is not yet fully understood. At high glucose concen-
trations, the rate of glucose consumption is higher, but 80% to 90% of it is converted to 
lactate. In contrast, at low glucose concentrations the rate of glucose consumption may 
be lower, but a much larger part of glucose is fully oxidised to CO2. 
Cell metabolism can be altered by using fed-batch cultures, initially keeping glucose 
concentration at low levels and then switching to continuous operation mode. This tactic 
has proven to lead to more efficient metabolic behaviours, in which fewer nutrients are 
consumed and less energy is required by the cell. For this purpose, Kholodenko et al. 
(1998) developed a method called "Metabolic Design Analysis", where they showed that 
it is possible to calculate the required changes in enzyme activities that bring about the 
desired pattern of steady-state metabolite concentrations and fluxes, therefore facilitating 
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the design of metabolism. 
As mentioned above, amino acids also constitute important substrates in mammalian 
cell cultures. The importance of each amino acid is determined by its relation to cell 
death, thus giving rise to two overall categories: the essential amino acids, the deprivation 
of which results in cell death, and the non-essential amino acids, which have a reduced 
effect on viability. This discrimination between amino acids and their individual categori-
sation appears to be cell-line dependent. For example, Duval et al. (1991) determined 
that for VO 208 hybridoma cells the essential amino acids are lencine, isoleucine, valine, 
threonine, phenylalanine, tryptophan and lysine, whereas Simpson et al. (1998) found that 
for NS1-derived murine hybridoma TB/C3 the essential amino acids are cysteine, thre-
onine, phenylalanine, leucine, tryptophan, valine, isoleucine, lysine, tyrosine, histidine, 
methionine and arginine. The only equation found in literature on amino acid uptake was 
proposed by da Silva et al. (1996). It is the same for all amino acids, essential and non-
essential ones, and considers amino acids to be growth limiting factors alongside glucose 
and glutamine, their consumption also following Monod-type kinetics. 
A final important component of metabolism is oxygen. Oxygen is necessary for the 
oxidation (catabolism) of nutrients and variations in its concentration in the culture are 
known to cause changes in metabolism. It has been suggested by Jan et al. (1997) that the 
specific rate of glucose uptake increases at higher dissolved oxygen concentrations with a 
higher proportion of glucose being metabolised anaerobically leading to increased levels of 
lactate formation. The same study also found that the specific glutamine utilisation rate 
increased at higher dissolved oxygen concentrations, even though there was no evidence of 
a change in the pattern of metabolism. In general, the rate of oxygen uptake is reported 
to be cell-line specific. Heidemann et al. (1998) report that there exists a critical concen-
tration at 1% of air saturation, and Jan et al. (1997) that murine hybridoma cultures can 
adapt to dissolved oxygen conditions in the range of 10% to 150% of air saturation. 
Cell Growth and Death Even though cell growth is a well-studied area of animal 
cell cultures, there appear to be many differences between the mathematical models that 
describe it. These differences mainly involve its dependency on nutrients, metabolites 
and oxygen. Cell growth has been mathematically related to glucose concentration alone 
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(Frame and Hu, 1991), glucose and glutamine (de Tremblay et al., 1992), glutamine, am-
monia and lactate (Bree et al., 1988), glucose and lactate (Kurokawa et al., 1994) and to 
all four nutrients and metabolites (Miller et al., 2000; Jang and Barford, 2000). All of the 
above models assume Monod-type kinetics. Lourenco et al. (1996) went on to add three 
more terms in the relationship proposed by Miller et al. (2000) for the effect of serum, 
oxygen and amino acid concentrations, which is probably a rather simplistic approach 
considering the high level of interaction between all these components. Tatiraju et al. 
(1999) have also suggested an equation for oxygen consumption and its relation to cell 
growth, which is of little use as it is decoupled from the other nutrients with which it has 
been proven to be associated. Similar models have been obtained for cell death, which 
relate the rate of cell death to glutamine, lactate and ammonia concentrations (de Trem-
blay et al., 1992; Bree et al., 1988), or glucose (Frame and Hu, 1991), or glutamine (Dalili 
et al., 1990), or ammonia and lactate (Batt and Kompala, 1989), or ammonia (Jang and 
Barford, 2000). 
Piirtner and Schafer (1996) compared a selection of models and model parameters 
that existed in the literature at that time and carried out an analytic error and range 
of validity analysis. They found significant variations in the values of maximum growth 
rate, yields and nutrient Monod constants that were used by other researchers. It was 
concluded that the models' predictions involved significant errors, particularly due to the 
lack of understanding of the real metabolism and the limited data ranges used for setting 
up the model. They further suggested that static batch cultures could be used, for ex-
ample, for the determination of maximum specific growth rate, but not for establishing 
a relationship between the growth rate and substrate concentration, whereas continuous 
cultures could yield reliable data due to the steady state operation conditions. For very 
low substrate concentrations they suggest using fed-batch cultures. Finally, they recog-
nised that for significant improvements, parameter identification techniques and control 
strategies need to be applied to mammalian cell cultures as has previously been the case 
in other biotechnological processes. 
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Figure 2.8: Control of the cell cycle (users.rcn.com). 
Cell Cycle 
There are two types of models describing the cell cycle: models based on mass balances on 
the G1, S and M cells (G2 cell cycle phase is generally ignored due to its short duration), 
and models that focus on phase transition regulation by cyclin-cyclin dependent kinase 
(CDK) complexes (see figure 2.8). The former are simpler and mainly descriptive, while 
the latter are a more faithful representation of the underlying mechanisms. Both types 
are considered here in the order mentioned above. 
In 1999, Uchiyama and Shioya constructed a simple mathematical model describing 
the cell cycle dependency of rice a-amylase production by recombinant yeast. This model 
introduced the concept of progression rate of the cells leaving a phase of the cycle, which 
was used in mass balances for each cycle phase and can be applied to other cell types too. 
The values of these rates appear to be functions of the culture temperature and substrate 
(glucose) concentration. 
When considering the phase transition regulation, G1—S and G2—M are the most im-
portant transitions of the cell cycle, therefore attempts have been made to model them 
mathematically. Novak and Tyson (1993) developed a model for the G2—M transition, i.e., 
for mitotic control, using the cell cycle control proteins Cdc2 and Cdc25, the associated 
cyclin, and the M-phase promoting factor, MPF (serine/threonine kinase). The proposed 
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model consists mainly of mass balances for the above components and, so far, there is 
little evidence for or against it. 
Based on the Novak and Tyson's work, Zheng et al. (2000) produced a qualitative 
analysis of the same mathematical model of the cell cycle. In this they discussed the 
existence, uniqueness, stability and instability of its singular point and the system bound-
edness without providing a physical explanation of their results. The same year, Hatz-
imanikatis et al. (1999b) formulated a mathematical model describing the regulation of 
the G1—S transition of the mammalian cell cycle. They used a network to depict the most 
important elements that regulate this phase transition, involving nine components that 
include cyclin E and its phosphorylated complexes with cdk 2, pocket proteins (pRb) and 
E2F. Hyperphosphorylation of pocket proteins is nearly coincidental to the release of E2F, 
a transcription factor. Once this factor is free, it is able to activate the transcription of 
genes involved in S phase activities including DNA polymerase and thymidine kinase. The 
cyclin E-cdk 2 phosphorylated complex plays an important role in the G1—S transition, 
as it contributes to the phosphorylation of pocket proteins, which leads to E2F release. 
The model, based on this complex biochemical regulatory network operating in a single 
well-mixed compartment of time-invariant volume, comprises of a series of dynamic mass 
balances for its nine components taking into account the chemical reactions between them. 
The model only considers cyclin E when describing the regulation of the G1 —S tran-
sition, even though, as previously mentioned, cyclin A is also present in this part of the 
cell cycle. This is believed to be adequate, as it has been shown by experimental data 
that among the cyclins synthesized during G1, only cyclin E expression affects cell cycle 
kinetics (Ohtsubo and Roberts, 1993). In fact, according to the same research, cyclin E 
accumulation appears to be rate-limiting for the transfer through the G1  phase. For ex-
ample, high cyclin E concentration during this phase results in a reduction of the duration 
of G1 , while, at the same time, the duration of the S and G2 phases is lengthened and, 
thus, the total duration of the cycle is not affected. Finally, in this work Hatzimanikatis 
et al. have taken into account the fact that apart from the availability of the appropriate 
cyclin subunit, the level of CDKs in each phase is also regulated by association with cyclin 
dependent inhibitors (Nurse, 2000). The checkpoint control role of CDKs ensures that a 
later event does not occur chemically or physically before completion of an earlier event. 
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In this way, mitosis only takes place when the genome is fully replicated and there is only 
one S phase in each cell cycle. The latter event appears to be ensured by the high levels 
of CDK activity during G2, which have been shown to block initiation of further S phase 
(Nurse, 2002). Moreover, Nurse and co-workers have proved that it is possible to inhibit 
cell progression into the S phase by reducing the supply of deoxyribonucleotides, thus 
blocking the event of mitosis (Nurse, 2000). This can be used to arrest cells in the G1  
phase, which may be beneficial for monoclonal antibody production as discussed in the 
antibody secretion section of this chapter. 
Implementation of the above model in the proposed research platform for the purpose 
of cell cycle control would require knowledge of a significant number of parameters, which 
can be specified experimentally through measurements of the concentration of six out of 
the nine components of the network. Unfortunately, the cell cycle is not further considered 
in this work due to lack of experimental techniques for obtaining the necessary parameter 
information in our laboratory, as well as concerns about model tractability. 
Antibody Production 
Antibody Synthesis Little work has been carried out so far in the field of monoclonal 
antibody synthesis from its main components, i.e., the two light and the two heavy amino 
acid chains. The mathematical model established for this cellular function was proposed 
by Bibila and Flickinger (1992), in an attempt to optimise the specific antibody secretion 
rate and, in this way, the volumetric productivity of MAbs. They use the model as a 
tool for the identification of the predominant factors that affect the specific antibody 
secretion rate and its association with the cell growth rate. The model consists of mass 
balances and rate equations and is broken into five distinct steps following which antibody 
synthesis takes place. It starts with intracellular heavy- and light-chain mRNA balances 
(transcription), continues with intraER such balances (translation), and proceeds with 
heavy- and light-chain assembly in the ER (MAb synthesis by the sequential addition 
of each of the four chains). An intraER MAb balance is then performed, followed by 
an intraGolgi one, after MAb glycosylation in these two organelles, the details of which 
are not included. The model is based on a steady-state assumption, which implies that 
there is no accumulation of heavy- and light-chain coding mRNAs, heavy- and light-chain 
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polypeptides or antibody assembly and transport intermediates. All required parameters 
for the model have also been provided based on the researchers' experimental work using 
9.2.27 hybridoma cell lines (Bibila and Flickinger, 1991b,a). Model simulations suggest 
that during exponential cell growth, the assembly of heavy and light chains is the most 
likely rate-limiting factor in antibody production. Under slow growth conditions though, 
the process of mRNA translation becomes rate-limiting. 
Antibody Secretion In the model by Bibila and Flickinger (1992) described above, 
an MAb balance is also performed in the extracellular medium. The proposed equation 
relates the rate of MAb secretion in the medium with the MAb intraGolgi concentration 
and the viable cell concentration in the medium. Nevertheless, it assumes that all viable 
cells have equal MAb production rates, which is contradicted by the fact that antibodies 
are not housekeeping proteins and their production rate is reported to depend on each cell's 
positioning on the cell cycle at any given time. Several opinions have been expressed about 
the nature of the dependency of antibody production on cell cycle. The maximum rate of 
antibody production has been linked to the G1 phase (Al-Rubeai and Emery, 1990), the 
S phase (Banik et al., 1996), the G2 —M transition (Aggeler et al., 1982), whereas others 
have reported that it is aphasic (IVIatherley, 1989), or even dependent on cell size (Lloyd 
et al., 2000). 
Recognising the necessity to distinguish between cell cycle phases when modelling 
MAb production, Suzuki and 011is (1989) developed an equation that incorporated the 
fraction of cells arrested in the Go phase and attributed different production rates to 
cycling and arrested cells. A similar equation was proposed by Jang and Barford (2000), 
while Tatiraju et al. (1999), following the same principles, developed an equation that 
included the specific growth rate. All three of these equations are based on the assumption 
that MAbs are produced at a higher rate when the cells are not proliferating, i.e., when 
they are in the G1 (or Go) phase of the cell cycle. Specific productivities of hybridomas 
are reported to be highest in nutrient-poor media, i.e., under conditions of starvation 
(Mastrangelo and Betenbaugh, 1998). However beneficial these conditions may be for 
MAb productivity, it is important to keep substrate concentrations at an adequate level 
for cell survival, otherwise the resulting apoptosis would consequently cause a decrease in 
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the level of MAb production. Even though MAb production does not seem to be inhibited 
by high MAb concentration in the medium (Miller et al., 2000), inhibition can be induced 
by high ammonia and lactate concentrations (Gaertner and Dhurjati, 1993). 
Glycosylat ion 
Unfortunately, no mathematical model exists specifically for the glycosylation of MAbs. 
Two models have been developed for protein glycosylation in general, but neither has been 
experimentally validated for hybridoma cell lines. 
The first model was developed by Shelikoff et al. (1996) based on a model protein, 
human prolactin, which was chosen for reasons of convenience since it has a single poten-
tial glycosylation site. This model relies on two major hypotheses: first, that the initial 
glycosylation event takes place in a defined region relative to the endoplasmic reticulum 
membrane, which is divided into distinct layers or regions, and, second, that it occurs 
in competition with protein folding events. The resulting model is one-dimensional and 
is mathematically analogous to a reaction occurring in a plug flow reactor. It does not 
account for variations in the oligosaccharide content of the protein or for further modifi-
cations of the protein in the Golgi apparatus. 
One year later, Umana and Bailey (1997) proposed a different, more elaborate model, 
for N—linked protein glycosylation. This consists of mass balances for 33 oligosaccharide 
species N—linked to a specified protein (interferon-'y) that is being transported through the 
different compartments of the Golgi complex. These compartments are the cis—, medial—, 
and trans—Golgi cisternae and the trans—Golgi network (TGN). The model also includes 
rate equations for the enzyme-catalysed reactions of oligosaccharide addition. These are 
collectively termed "Central Reaction Network" (CRN) and describe the N—linked glyco-
sylation pathway in detail. The CRN determines the major types of structures into which 
N—linked oligosaccharides are normally classified. The part of the glycosylation process 
taking place in the endoplasmic reticulum is not modelled in detail and is assumed to be 
complete and correct. 
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2.3 Discussion 
The biological background of the processes examined in this work was presented in this 
chapter. A review of the relevant literature identified the most important culture variables 
and an analysis of existing modelling studies highlighted the strengths and weaknesses of 
each approach. Finally, the most relevant to this thesis, structured and unstructured, 
models of cell cultures and cellular functions, such as protein synthesis and glycosylation, 
were discussed. 
Chapter 3 
Mathematical Model, Model 
Analysis and Experimental 
Methods 
3.1 Mathematical Model 
The model presented herein addresses the most important aspects of mammalian cell 
cultures affecting MAb production. It is a hybrid (structured/unstructured) model that 
is based on experimentally validated mathematical structures that already exist in the 
literature and cover individual aspects of the cultures. These models have been modified 
to form a coherent flow of information from cell growth kinetics to product formation, 
finally leading to the determination of MAb productivity and glycosylation (see figure 3.1 
for a simplified schematic). Further modifications were made to allow for the inclusion 
of important culture factors not accounted for in the original models, particularly for 
the extent of product glycosylation. The resulting formulation is the first of its type to 
incorporate cell growth kinetics, cell death, cell metabolism, cell cycle, and MAb synthesis, 
glycosylation and secretion. 
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Cell growth and death 
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Protein glycosylation 
Rate of protein transfer 
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Figure 3.1: A simplified schematic of the model structure and the flow of information. 
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3.1.1 Cell Growth and Death 
In the chosen model for cell metabolism (Jang and Barford, 2000),which, like the rest 
of the model, assumes perfect mixing of the culture, only the two key nutrients, namely 
glucose and glutamine, are considered as the limiting factors for growth while the inhibitory 
products taken into account are ammonia and lactate. The model includes a total material 
balance: 
dY 
dt = Fin — Font, 
	 (3.1) 
where, V is the total volume of the culture (L) and Fin, Font are the flowrates in and out 
of the bioreactor (L/h), respectively. A material balance for the viable cells within the 
bioreactor is given by: 
dt 	= Xv — tidV Xv — FautXv, 
where, Xv is the concentration of viable cells in the bioreactor (cell! L) and It , Ad are the 
specific cell growth and death rates (h-1), respectively. The material balance for all the 
cells (viable and non-viable) in the bioreactor is: 
d(V Xt )  = itV — FoutXt, 	 (3.3) dt  
where, Xi is the total cells concentration in the bioreactor (cell' L). 
The specific growth rate for mammalian cells can be determined using the following 
equation: 
= ilmax flimfinh, 	 (3.4) 
where, Amax is the maximum specific growth rate (h-1) and flint,  fi rth are the nutrient 
limitation and product inhibition functions, respectively. The latter arc defined as: 
[GLC] 	[GLN] 
fh. = ( K gie + [GLC] )( K giu + [GLN] )' 
(3.5) 
and 
K Ian,„ 	K hue 	\ (3.6) ftnh 	Klantin [AM lt/1] )( K ae  + [LAC] 1• 
In equations 3.5 and 3.6, [GLC], [GLN], [AM M] and [LAC] are the extracellular concen-
trations of glucose, glutamine, ammonia, and lactate (mM), respectively. K91, and KgIn 
are the Monod constants for glucose and glutamine (mM), respectively, while K antrn and 
d(V Xv ) (3.2) 
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If ha , are the inhibition constants for ammonia and lactate (mM), respectively. 
Similarly, the specific cell death rate is given by: 
lid 	 K" 
ax 
 1±( 
= 	
ttd,m
d' 
 m 
n  n > 1, 	 (3.7) 
fAMM] 
where, Adonax is the maximum specific death rate (h-1), and Kd,amm. is the constant for 
cell death by ammonia (mM). 
3.1.2 Cell metabolism 
The concentrations of the nutrients and their products can be obtained by performing 
material balances on each one of them around the bioreactor. Therefore, for glucose: 
dt 	= Q glcV Xv Fi
n [GLC]in — Foutp LC], 
with 
Q glc = 	± mglc, 	 (3.9) 
Yx,gic 
where, Qgic  is the specific glucose consumption rate (mmol I cell I h),17,,,g ie is the cell yield 
on glucose (cell I mmol), and mg ie is the maintenance energy of glucose (mmol I cell1h). The 
initial equation for the specific glucose consumption rate proposed by Jang and Barford 
included the addition of a term for glucose consumption by glucokinase: 
Qexglc 
--exgx 7  [GLC] K 
where, Qexglc  is the specific glucose consumption rate by glucokinase (mmol I cell I h), and 
Kexg ie  is the Monod constant of glucose when present in excess amount (mM). This term 
was removed to give the above expression, 3.9, as it was found to have a negligible contri-
bution to Qg ie , while adding a further two parameters to the overall model. Its removal is 
further supported by the work of Tatiraju et al. (1999). 
Similarly, for glutamine: 
dt 	— — Q sinV Xv — Ka,
g inV[GLN] 	 — FontV[GLN], 
with 
1-1  
Qgln = 	Mgin 
x,gln 
d(V[GLC]) (3.8) 
[GLC] 
d(V[GLN] ) (3.10) 
(3.11) 
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and 
ingin = a2 + [GLN]' 
where, Q gh, is the specific glutamine consumption rate (mmol/cell/h), Yx ,on is the cell 
yield on glutamine (cell Immol), Kd,gln  the specific rate of spontaneous glutamine degra-
dation (12-1), mgin is the maintenance energy of glutamine (mmol I Milli), and (Ai, a2 
are the relevant constants (mML/cell/h and mM, respectively). Equation 3.11 was also 
modified from the original by Jang and Barford, as the glutamine maintenance coefficient, 
mon , was later added according to the equation proposed by Tatiraju et al. (1999) result-
ing in a better representation of glutamine metabolism. 
For ammonia: 
dt 	= QamrnVXv Kd,gi
n V [GLN] — Fout [AMM], 
with 
Qamm = Yarnra,glnQ gin, 
	 (3.14) 
where, 	is the specific ammonia production rate (mmol I cell I and Yan,,,,gb, is the 
yield of ammonia on glutamine (mmol/mmol). 
Finally, for lactate: 
d(V[LAC]) 
dt 	= (Awl/ Xv — Fout[LAC], 
Qtac = Ylac,g1c62gic, 
where, Qiac is the specific lactate production rate (mmol/cell/h) and Yiacsin  is the yield 
of lactate on glucose (minol I mmol). 
3.1.3 Antibody Synthesis and Secretion 
The chosen model for MAb synthesis is a structured kinetic model developed by Bibila and 
Flickinger (1992) that traces the intracellular pathway of MAb production. This model is 
based on the assumption that there is no intracellular accumulation of any of the species 
involved in the antibody secretion pathway (heavy- and light-chain coding inRNAs, heavy-
and light-chain polypeptides, and antibody assembly and transport intermediates). The 
al  [GLN] (3.12) 
d(V[AMM]) (3.13) 
with 
(3.15) 
(3.16) 
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model further assumes that there is no proteolytic or other degradation of the heavy- and 
light-chain polypeptides in the cell, as well as that no free heavy or light chains or assembly 
intermediates escape from the endoplasmic reticulum during processing. 
The original model has been modified in three ways: 
1. Because the focus in this part of the model is on single MAb-producing cells, the 
terms accounting for dilution have been removed, assuming that cell growth has a 
negligible dilution effect. 
2. A term representing the distinction between proliferating and non-proliferating cells 
has been added to the equation for MAb secretion to the extracellular medium 
according to the relevant equation proposed by Tatiraju et al. (1999) (equation 
3.27), and 
3. Two factors, El and E2, have been added to account for the efficiency of the glycosyla-
tion in the ER (equation 3.25) and the Golgi apparatus (equation 3.26), respectively. 
This was carried out following the relevant suggestions by Bibila (1991). 
The intracellular heavy- and light-chain mRNA balances are: 
dm1_ 
dt 	NHS('— KmH, 
and 
dmL  	 = 
dt 	NLSL— KmL, 
where, rnj and mL are the intracellular heavy- and light-chain mRNA concentrations 
(mRNAs/cell), NH and NL are the heavy- and light-chain gene copy numbers (gene/ cell), 
SH and SL are the heavy- and light-chain gene specific transcription rates (mRNAsIgenelh), 
and, finally, K is the heavy- and light-chain mRNA decay rate (//, 
The intraER heavy and light chain balances are: 
= THMH RH, 
d[L] 
= Tont, — RL, 
(3.17) 
(3.18) 
d[H]  
dt 
and 
dt 
(3.19) 
(3.20) 
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where, [H] and [L] are the free heavy and light chain concentrations in the ER (chain' cell), 
TH and TL are the heavy- and light-chain specific translation rates (chainlmRNAI h), and 
RH and RL are the rates of heavy- and light-chain consumption in assembly (chain Icell1h). 
MAbs consist of two heavy (H) and two light (L) amino acid chains. Each molecule is 
synthesised in the ER following the sequence described below: 
H H, 112 
H2 L = H2 L 
1-12 L + L H2L2. 
If the rates of heavy- and light-chain consumption in the assembly are given by: 
Rx = 3 —
2 KA [H] 2 , 	 (3.21) 
RL = 2K A[H2][L] + K A[H2 L][L], 	 (3.22) 
then intraER balances can be performed on the assembly intermediates: 
d[H2
] 
 
1 KA[H] 2  — 2K [H2] [L] dt 	3 
d[H2L] = 2K A[I12][L] ICA[H2L][L]' dt 
where, [H2 ], [H2.L] are the concentrations of the assembly intermediates in the ER (molecule/ cell), 
and KA is the assembly rate constant ((moleculel cell)h) - 1 . 
A balance can then be performed on the assembled MAb structure ([112L2]ER) in the 
ER: 
d[H2L2]ER 
 KA[H2L][L] — KER[H2L2]ER, dt 
where, [H2L2]ER is the MAb concentration in the ER (molecule' cell), and KER is the rate 
constant for ER-to-Golgi antibody transport (h —1 ). Once the MAb is assembled in the 
ER, it proceeds to the Golgi apparatus, where the main part of its glycosylation process 
takes place. 
An intraGolgi MAb balance gives: 
d[H2 L2 ]G 
dt 	_ KER[1-12L2]ER — Kc[H2L2]G, 
(3.23) 
(3.24) 
(3.25) 
(3.26) 
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where, [H2 L2 ]G is the MAb concentration in the Golgi (molecule/cell), el is the ER gly-
cosylation efficiency factor, and KG is the rate constant for Golgi-to-extracellular medium 
antibody transport (h -1 ). 
Finally, the expression for antibody secretion (production) is: 
d(V[MAb])  
= dt 	VT2 71.11)C2MAbVXv — Fout
[M Ab], 	 (3.27) 
with 
QMAb = E2AKC[EI2L2]G, 	 (3.28) 
where, QMAb  is the specific MAb production rate (mg/cell/h), A is the molecular weight of 
IgG1 (9 /mol), and E2 is the Golgi glycosylation efficiency factor. In equation 3.27, [MAb] 
is the MAb concentration in the culture, and 71, -y2 are constants. This equation has 
the advantage of distinguishing between the MAb production from proliferating and non-
proliferating cells, as suggested by the corresponding equation in the model by Tatiraju 
et al. (1999): 
dt 	= (72 - 71/2)Xv• 
It is important to note that 71 and 72 do not have the same values in equation 3.27 as 
in the original expression by Tatiraju et al., as the term QMAb  has been introduced to 
accommodate the inclusion of the model of the intracellular synthesis pathway. 
The differentiation between proliferating and non-proliferating cells also appears in 
the corresponding equation proposed by Jang and Barford (2000) in accordance with 
observations from relevant experiments: 
d(V[MAb]) 	[GLN] 	Font  )X, 	[MAb], dt 	= QMAb(  [GLN] + Kgin 	V 
where, 
QMAb  = Qc( 1 fG0) QG0fG01 
and 
Xvo 	— a 
fGo = X„ 
In the above expressions, Q, is the specific antibody production rate for cycling cells, and 
Quo is the specific antibody production rate for cells arrested in the Go phase (mg /cell / h). 
Moreover, ko is the fraction of Go cells, X„ is the concentration of viable Go cells (cell/ L), 
d[MAb] 
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a is the specific death rate of cycling cells (h -1 ), and b is the difference between the specific 
death rates of Go cells and cycling cells (h —1), both in steady state. The drawback of 
this method of determining the MAb concentration in the culture is that the values of 
a and b need to be known a priori. Furthermore, the major advantage of equation 3.27 
over those by Tatiraju et al. and Jang and Barford is that the former calculates the MAb 
concentration based on both the cell metabolism, which determines the growth rate and 
the concentration of viable cells, and on the MAb synthetic pathway. 
3.1.4 Antibody glycosylation 
As has been previously mentioned, only two models for protein glycosylation are available 
in the literature, and neither one of them has specifically been developed or has been 
validated for the production of MAbs (Shelikoff et al., 1996; Umana and Bailey, 1997). 
Out of these, the model by Umana and Bailey (1997) was chosen for implementation, as 
it takes into account protein glycosylation in both the ER and the Golgi apparatus. More 
specifically, the model assumes complete protein glycosylation in the ER that accounts for 
the en bloc addition of the N—linked oligosaccharide precursor. The protein then proceeds 
to the cis-Golgi network, which is not considered in the model. After that it travels through 
the remaining compartments, namely the cis—, medial—, and trans— Golgi cisternae 
(Golgi stack), and the trans—Golgi network (TGN). There is some controversy about the 
number of cisternae in the Golgi stack, but in the present model only three are considered 
(Umana and Bailey, 1997). 
Glycoprotein transport through the Golgi apparatus is modelled in the same way as 
in previous models of protein traffic through the secretory pathway of the cell (e.g., Bibila 
and Flickinger (1991b)). The model consists of mass balance equations for a soluble 
glycoprotein that is being secreted to the extracellular space and for the oligosaccharide 
species N—linked to it; and of rate equations for the 33 oligosaccharide addition/trimming 
reactions. Four basic assumptions are made: 
1. Intercompartmental protein transfer follows first-order kinetics, 
2. The contents of a compartment are spatially homogeneous, 
3. There is no loss of protein during transport through the Golgi, and 
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4. The dilution of compartmental components due to cell growth is negligible. As 
reported by Bibila and Flickinger (1991b), glycoproteins require approximately 20 
minutes to go through all of the Golgi compartments, while typical doubling times 
of mammalian cells in culture are around 1000 minutes (Arathoon and Birch, 1986). 
This implies that glycoproteins experience a practically constant volume of the com-
partments during their processing in the Golgi. 
The mass balance equation for a glycoprotein in the first compartment, i.e., the 
cis—Golgi cisternae, is: 
dpi 
dt 	
fiKER  AL/21ER 
N 	V  Xv — K 
The mass balances for the remaining compartments are: 
dpi 
dt = 	— pi) , 2 	4, 
where, pi is the amount of glycoprotein in compartment j (mol), 1 being the cis—, 2 
the medial—, and 3 the trans—Golgi cisternae and 4 standing for the TGN, and N is 
Avogadro's number. In the original model by Umaiia and Bailey the rate of protein transfer 
into the Golgi apparatus was represented by variable qp, which took values between 1 and 
2000 pmo1/10 6 cells/24h. In this combined model, however, the rate at which the MAb 
molecules exit the ER (and thus enter the Golgi apparatus) is already computed in section 
3.1.3 (KER[H2L2]ER) and is therefore used in equation 3.29 instead of qp. The advantage 
of this modification is that the biosynthesis section is adjusted specifically to the case of 
MAb production and takes into account the dynamic behaviour of its production rate. 
There are 33 possible enzyme-catalysed reactions that can occur in the Golgi apparatus 
resulting in the addition of the oligosaccharides on the protein, which are collectively 
referred to as the Central Reaction Network (CRN) and can be seen in figure 3.2. It 
is assumed that the rates of these reactions can be described by Michaelis-Menten type 
kinetics (Rearick et al., 1979; Schachter et al., 1989; Albe et al., 1990) and that product 
inhibition of the reactions is insignificant (Umana and Bailey, 1997). 
The reactions are thought to be catalysed by 8 enzymes. As a result, in most reactions 
multiple substrates compete for one binding site. At this stage, the original model is 
(3.29) 
(3.30) 
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Table 3.1: Values of index i corresponding to each oligosaccharide (Urnana and Bailey, 
1997). 
Oligosaccharide i Oligosaccharide 
M9 1 M3Gn3 ' G 18 
M8 2 M3Gn4G 19 
M7 3 M5GnGn,6  20 
M6 4 M4GnGn b  21 
M5  5 M3GnGn b  22 
.M5Gn 6 M3 Gn2Gm b  23 
M4 Gil 7 M3Gn3Gn b 24 
M3Gn 8 M3Gn3 / Gn b 25 
/V/3Gn2 9 M3 art 4 Gil b 26 
M3Gn3 10 M5GnGn bG 27 
11,13 G723 11 M4 GnGnbG 28 
M3Gn4 12 /143GnGn bG 29 
M5GnG 13 11/13Gn2Gn bG 30 
1114GnG 14 M3Gn3Gn b G 31 
M3GnG 15 Il4.3Gn3 iGnbG 32 
M3Gn2G 16 M3Gn4Gn bG 33 
M3G713G 17 
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Figure 3.2: Central reaction network (UI-liana and Bailey, 1997). 
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modified by assuming Michaelis-Menten kinetics for competitive inhibition (Montgomery 
and Swenson, 1976), and express the rates of these reactions as follows: 
Umk,jV XvpiXki 
(3.31) 
where, r k j is the rate of reaction k in compartment j (mol/h), Vnikoi denotes the apparent 
maximal velocity of reaction k in compartment j (mo//10 6 cells/h), andK,,,k is the 
apparent dissociation constant for reaction k in compartment j (M). VG,j is the volume 
of compartment j (L) and xj,i denotes the mole fraction of oligosaccharide i, substrate for 
reaction k, on the glycoprotein in compartment j. Finally, index 1 indicates the reactions 
that are catalysed by the same enzyme as reaction k. The apparent maximal velocity is 
given by: 
Vinko = ek,3Vm,k, 	 (3.32) 
where, ek,i is the spatial distribution of the enzyme catalysing reaction k is compartment j 
(dimensionless) and Vm,k is the apparent maximal velocity of reaction k (mo1/10 6cells/h). 
The amount of each oligosaccharide in a compartment is expressed as the product of its 
molar fraction and the amount of glycoprotein in that compartment. The oligosaccharide 
molar fractions in compartment 1 are given by the following mass balance: 
dxi 
Pi 	KER
[2L2]ER  
dt 
VX,,(ERi — x1 ,1 ) + 	 1 i 33, 1 k 33. 
k 
(3.33) 
The mass balances for the oligosaccharide molar fractions in the remaining compartments 
can be expressed as follows: 
dxi 	
kapj—i 	— 	(Vi,krk,i), 1 i 33, 1 k 33, 2 j 4, dt 
(3.34) 
where, ERi is the mole fraction of oligosaccharide i on the glycoprotein as the latter exits 
the ER and ?3i,k is the stoichiometric coefficient of oligosaccharide i in reaction k. 
rk,3 pi 
VG,j 
, 1 i 33, 1 k< 33, 1 j 4, 
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3.2 Model Analysis 
Parameter analysis methods can aid model development by determining which parame-
ters can be uniquely identified from a specified input-output experiment (parameter 
identifiability (Walter, 1987)), or which parameters significantly affect the model output 
(parameter sensitivity analysis (Saltelli et al., 2000)). This information can then be 
used to reduce the number of parameters to be estimated and, hence, to avoid exces-
sive experimentation. It becomes particularly relevant in the development of models for 
biological systems as experiments in this field are expensive and time-consuming. 
There are two types of identifiability analysis: 
1. Structural identifiability, also known as deterministic or a priori identifiability, which 
assumes perfect (noise-free) data (Walter, 1987), and 
2. Numerical identifiability, or a posteriori identifiability, which examines the model in 
the presence of real, noisy data (Walter, 1987). 
If parameters are structurally identifiable, numerical identifiability analysis is the same 
as sensitivity analysis in the context of parameter estimation (problem of parameter esti-
mation accuracy). For linear models several methods can be applied to examine which, 
if any, model parameters are identifiable, namely Laplace Transform or Transfer Func-
tion approach, Taylor Series expansion of the Observations, Markov Parameter Matrix 
approach, Modal Matrix Approach, and Exhaustive Modelling approach. When dealing 
with structural identifiability analysis, it is difficult to generalise conclusions drawn from 
specific cases, as no consistent simple structure carries over from one case to another (Wal-
ter, 1987). In fact, for linear systems with more than one inputs, identifiability results 
may depend on whether the inputs are applied simultaneously or separately, as well as on 
the shape of the inputs. Furthermore, it should be borne in mind that structural identifi-
ability refers to an idealised situation and that, even if a model is structurally identifiable, 
subsequent parameter estimation can still fail due to excessive experimental error. This 
points out the need for numerical identifiability analysis, which can determine which, if 
any, parameters can be uniquely identified based on the available set of measured vari-
ables. 
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Previous work has shown that application of numerical identifiability to dynamic mod-
els with a high number of nonlinearly related parameters can prove computationally dif-
ficult if not impossible (Ljung and Glad, 1994; Sidoli et al., 2005). Parameter sensitivity 
analysis, on the other hand, is a less computationally demanding method, which studies 
how a variation in the model output can be apportioned to the variation of the differ-
ent parameters (Saltelli et al., 2000). The choice of method for parameter analysis can 
be regarded as a trade off between the information gained and the effort required, and 
depends on the complexity of the mathematical formulation under examination. In this 
work, parameter sensitivity analysis was implemented. 
3.2.1 Parameter Sensitivity Analysis 
Sensitivity analysis is used to increase confidence in the model and its predictions by 
providing an understanding of how its outputs respond to changes in the inputs, such 
as model parameters or model-independent variables, and is considered a prerequisite for 
model building in any setting. Three categories of sensitivity analysis methods exist, 
screening, local and global sensitivity analysis (Saltelli et al., 2000). 
Factor Screening Factor screening is suitable for models with a large number of input 
factors, which are therefore computationally expensive to evaluate. It is reported to be 
able to economically handle models with hundreds of input factors. Nevertheless, this 
type of method only yields qualitative results, i.e., it only ranks factors in order of impor-
tance, without quantifying each factor's impact on the model output. The principal factor 
screening methods include one-at-time design, Morris' design, Cotter's Systematic Frac-
tional Replicate Design, Iterated Fractional Factorial Design, and Sequential Bifurcation 
(Saltelli et al., 2000). 
Local Sensitivity Analysis Local sensitivity analysis concentrates on the local impact 
of the factors on the output of the model and is usually carried out by computing partial 
derivatives of the output functions with respect to the input factors. In order to compute 
these derivatives two methods are used, namely Finite Difference Approximation and the 
Direct Method. Their use for predictive models should be limited to the case of linear 
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models or models with modest factor variations. Local sensitivity analysis methods are 
not suitable for nonlinear models as they are affected by uncertainties of different orders 
of magnitude, and are therefore riot examined here (Saltelli et al., 2000). 
Global Sensitivity Analysis Global sensitivity analysis is the only method that pro-
vides quantitative results while examining the entire range of parameter values (Saltelli 
et al., 2000). This is of particular importance in biological modelling, since model pa-
rameters can vary within large intervals depending on their physiological meaning. An 
illustrative example is that of parameter KA of the proposed model, which takes values 
between 10 -6 and 10 -12, with its nominal value being 10 —9 (Bibila and Flickinger, 1992). 
An additional advantage of global sensitivity analysis is that the estimates of individual 
parameters are evaluated while varying all other parameters as well. In this way, the 
relative uncertainty of each input is taken into account, revealing any existing first order 
interactions. Global sensitivity analysis can aid in model building by identifying the fac-
tors, i.e., the model inputs in the form of variables and parameters, which contribute the 
most to model variability. The interest of this thesis was in determining which model para-
meters have a significant impact on the output, and therefore require further investigation 
to determine their values with high precision. A number of global sensitivity analysis 
techniques can be used to calculate the desired sensitivity estimates, such as correlation 
ratios (Kendall and Stuart, 1979; McKay, 1995), the Fourier Amplitude Sensitivity Test 
(Cukier et al., 1973a,b, 1978; Schaibly and Shuler, 1973), and the Sobol' method (Saltelli 
et al., 2000; Sobol, 2001). The FAST and Sobol' methods, for all intents and purposes, 
are equivalent. 
Sobol' Method 
Sobol' is a variance-based Monte-Carlo method that allows the computation of both the 
sensitivity indices of individual parameters (Sobol' indices (Sobol, 2001)), Si, and the first 
order interactions between these parameters through the ratio of each sensitivity index to 
the corresponding total sensitivity index. The Sobol' method (Sobol, 2001) is based on 
the ANOVA (Analysis of Variances) decomposition of a given function into summands of 
1 
fo 
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increasing dimensionality, which for an integrable function f(x) defined in I n looks like: 
n 
f (x) = fo + 
	 - • • xis ), 1 	i1 < • • • < is 	n, 	(3.35) 
s=1 ii<••<is 
and means that: 
f(x) = fo fi (xi ) + fij 	Xj) 	• • ' 	f12.-n (X1 x2 7 	7 Xn) (3.36) 
If 
fis—if,(xii, • • • 7 Xis)dXk = 	f or k = 	• • • , 25, 	 (3.37) 
it follows that the factors in 3.35 are orthogonal and can be expressed as integrals of f (x): 
f (x)dx = fo, 
I f (x) H dxk = fo + fi(xi), koi 
f f(x) 1.1 dX k = fo fi (xi ) + fi (x j ) + fij (xi , X 
and so on. 
Let us assume that f (x) is square integrable, which means that all the fil ...is in 3.35 
are square integrable too. Squaring 3.35 and integrating over /", we get: 
f f 2 (x)dx — f 
n 
s=1 <•••<is 
f f 	- 
If x were a random point uniformly distributed in I n, then f (x) and fis ...i.(xj1 , • • • 
would be random variables with variances: 
D = f f 2dx — f (2) , and 	= f f 	• • dxis , 
respectively, with 	
n 
D= 
s=1 <•••<is 
The global sensitivity indices, a measure of the main effect of each factor on the model 
output, can then be defined as: 
-9— 	 11.-ts — D
i 
 D 
(3.38) 
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with 
n n 
L. E sii...is = 1. 
s=1 ii<•••<ts 
If we now consider an arbitrary subset of in variables, where 1 < m < n — 1, namely 
y = (xki , • • • , xk„,), and if z is a set of n — m complementary variables, then the variance 
corresponding to the subset y can be defined as: 
Dv = 	 K = (ki, • • - , km ). 	 (3.39) 
s=1 (ii <•••<is)EK 
Similarly, the variance D, can be introduced. Then the total variance corresponding to 
the subset y is: 
Dy tot = D — Dz. 
It is then possible to define the two global sensitivity indices for subset y: 
D 	 D tot 
Sv = --Y- and S t't —  Y  D 	 D 
From the above it is obvious that S tyot = 1 — S, and that 0 < Sy < S y" < 1. The two 
extreme possibilities correspond to the following cases: 
Sy = styot = 0 means that f(x) does not depend on y, and 
Sy = S tvot = 1 means that f (x) depends only on y. 
These indices can be used for estimating the influence of individual parameters or 
groups of parameters on the model output in order to investigate the tuning importance 
of each parameter as suggested by Saltelli et al. (2000). The parameters with very low 
sensitivity indices can be fixed at their nominal value, thus simplifying the model, while 
the values of those with high sensitivity indices will have to be estimated using experimen-
tal data. An important benefit of the Sobol' method is that, along with the sensitivity 
indices, it also provides the total sensitivity indices, which allow us to examine the possible 
interactions between two or more model parameters at no additional computational cost. 
3.2.2 Optimal experimental design 
Parameter estimation for models of cell culture systems is usually carried out using already 
existing (most often, batch) data. However, a unique identification of the parameter set is 
only possible if the available data are sufficiently rich (Versyck et al., 1997). Furthermore, 
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measurement noise and sampling frequency also influence parameter accuracy. The use 
of model-based experimental design can result in significant improvements in parameter 
confidences (Versyck et al., 1997; Nathanson and Saidel, 1985; Munack and Posten, 1989). 
Optimal experimental design targets the determination of input profiles that generate 
informative experimental data, which then enable accurate parameter estimation. This 
comes as a result of observations that highly dynamic occurrences benefit the estimation 
process. For example, it has been shown that a fed-batch experiment with time-varying 
feed rate leads to more accurate parameter estimates that a batch experiment of the same 
system (Munack, 1989; Munack and Posten, 1989). 
The application of optimal experimental design tools to models of bioprocesses has so 
far been limited to the food microbiology sector (Bernaerts et al., 2000). Versyck et al. 
(1997) have used optimal experimental design to improve parameter estimates for Monod-
and Haldane-type kinetic models, but used simulated experiments to generate data in-
stead of performing cultures of microorganisms exhibiting such growth behaviour. To my 
knowledge, optimal experimental design has not yet been used for mammalian cell culture 
models. These systems pose significant challenges, such as high numbers of model para-
meters, limited availability of intracellular measurements, difficulty of obtaining dynamic 
intracellular data, and high experimental error. The use of small, mostly unstructured 
models for such applications is the obvious first step towards establishing these methods 
in bioprocess model development. 
As mentioned above, optimal experiments are designed to improve model accuracy by 
reducing parameter uncertainty. The latter is expressed through the size of the variance-
covariance matrix 
V = V(6,0) 
where, B is the vector of the best parameter estimates and is the vector of the experiment 
decision variables and contains the variances of individual parameters and covariances of 
pairs of parameters. The aim of optimal experimental design is to minimise some metric 
of this matrix or maximise the same metric of the inverse of V, which is known as the 
Fisher Information Matrix, M. Several criteria exist that can achieve this: 
1. D-optimal design minimises the volume of the confidence ellipsoid, i.e., the determi-
nant of V, and is independent of parameter scales (Jacques, 1998), 
3.3. Materials and Methods 	 47 
2. E-optimal design minimises the length of the principle axis of the confidence ellipsoid, 
i.e., the length of the largest eigenvalue of V (Jacques, 1998), 
3. A-optimal design minimises the average variance of the parameter estimates, i.e., 
the trace of V, and is affected by parameter scales (Jacques, 1998), and 
4. M-optimal design (Nathanson and Saidel, 1985) is based on the implementation of D-
optimal design and the minimisation of the angle between the indifference ellipsoid 
axis and the reference axis in the parameter space. The latter seeks to reduce 
parameter correlation (Sidoli et al., 2004). 
D-optimal design is the most widely used (Jacques, 1998) and was employed in this thesis. 
3.3 Materials and Methods 
3.3.1 Cell Line and Maintenance 
The cell line employed for this thesis is the hybridoma HFN 7.1 (CRL-1606 from ATCC) 
producing a IgG1 monoclonal antibody against human fibronectin. The culture medium 
was high glucose (4.5 g/L) Dulbecco's modified Eagle's medium (DMEM, Gibco) with 
newborn bovine calf serum (BCS, ATCC). At the time of initial thawing of the cells, the 
concentration of the culture medium was 90% DMEM and 10% BCS. Once a sufficient cell 
bank had been developed, the cells were adapted to 95% DMEM and 5% BCS and finally 
to 97.5% and 2.5% BCS by a series of at least 5 passages each time. Cells were stored 
in 95% culture medium and 5% diniethyl sulfoxide (DMSO) at —86°C for 24 to 48 hours 
and were then transferred to liquid nitrogen storage (-160 °C). The thawing procedure 
consisted of rapid agitation of the vial containing the cells in a 37°C water bath for 40-60 
seconds, after which the cells were suspended in 25 ml in a TC-75 flask according to ATCC 
instructions. 
3.3.2 Culture Systems and Operation 
Tissue culture and shake flasks were both used in the culture of the hybridoma cells. 
As mentioned above, tissue culture flasks, which are normally used for adhesive cells, 
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were employed just after cell thawing and for the process of adaptation to lower serum 
conditions. Once the cells achieved satisfactory growth rates following changes in the 
culture environment, they were transferred to shake flask cultures. In these the cells were 
grown in suspension and exhibited larger and rounder shape, both morphological signs of 
healthy cells. Cultures were carried out in a CO2 incubator, where the temperature was 
controlled at 37°C, the rotation speed at 125 rpm and the CO2 air concentration at 5% 
v/v. 
3.3.3 Assays 
For determination of nutrient, metabolite and antibody concentration in the culture su-
pernatant, 1.5mL samples were withdrawn from the culture, the cells centrifuged at 10 4g 
for 5 minutes in an Eppendorf microfuge, and the supernatants stored at —20 °C. 
Nutrients and Metabolites Glucose, glutamine, lactate, and ammonia concentrations 
of supernatant samples were determined using the YSI Bioprofiler 200 by Nova Biomedical, 
U.K. Calculations are based on ion exchange theory, as the instrument uses suitable ion-
selective permeable membranes and reference electrodes. Glucose measurement is based 
on the level of H202 produced during the enzymatic reaction between glucose and oxygen 
molecules in the presence of the glucose oxidase enzyme. Lactate measurement is based 
on the level of H202 produced during the enzymatic reaction between lactate and oxygen 
molecules in the presence of the lactate oxidase enzyme. Glutamine measurement is based 
on the level of glutamate produced during the enzymatic reaction between glutamine 
and water molecules in the presence of the glutaminase enzyme. Finally, ammonium 
concentration is established directly based on the associated electrical potential. 
Enzyme-Linked ImmunoSorbent Assay Determination of antibody concentration in 
a supernatant sample can be carried out using high performance liquid chromatography 
(HPLC) or enzyme-linked immuno-sorbent assay (ELISA), the latter being more sensitive. 
Antibody concentration was measured using indirect sandwich ELISA. In this method, 96-
well plates (non-cell culture treated) were employed according to the following protocol: 
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1. Add 100 pl of 1 pg/ml anti-human fibronectin antibody from rabbit (Sigma-Aldrich 
F3648) in coating buffer (0.05 M sodium bicarbonate, pH 9.6) to each well. Seal 
plate and incubate overnight (16-20 hours) at 4°C on a level surface. 
2. Block non-specific binding by adding 250 pl of blocking buffer (250 ml coating buffer 
with 1.25 g cassein hammerstein) to each well. Seal plate and incubate at room 
temperature for 1 hour. 
3. Empty plate and wash 3 times with washing buffer (phosphate buffered saline with 
0.05% Tween). 
4. Add to each well 100 pl of 1mg/m1 human fibronectin (Chemicon International 
FC010) diluted in PBS at a ratio of 1:5,000. Seal plate and incubate at 15-25°C for 
1 hour on an orbital plate shaker. 
5. Empty plate and wash 3 times with washing buffer. 
6. Add to each well 100 pl of standards and samples containing anti-human fibronectin 
antibody from mouse (Sigma-Aldrich F0791) diluted in PBS at a ratio of 1:5,000. 
Seal plate and incubate at 15-25 °C for 2 hours on an orbital plate shaker. 
7. Empty plate and wash 3 times with washing buffer. 
8. Add to each well 100 p1 of 6.4mg/ml anti-mouse Fc antibody from goat (Sigma-
Aldrich A0168) diluted in PBS at a ratio of 1:10,000. Seal plate and incubate at 
15-25 °C for 1 hr on an orbital plate shaker. 
9. Empty plate and wash 3 times with washing buffer. 
10. Dissolve 1 tablet of 3,3',5,5'-tetramethylbenzene (TMB, Sigma-Aldrich T3405) in 10 
ml of 0.05 M phosphate-citrate buffer, pH 5.0 (substrate buffer). Add 2 pl of fresh 
30% hydrogen peroxide per 10 ml of substrate buffer solution immediately prior to 
use. Add 100 pl of the resulting solution to each well. Seal plate and incubate at 
15-25°C for 10-45 minutes on an orbital plate shaker. 
11. Stop the reaction by adding 50 pl of 2.5 M sulphuric acid solution to each well. 
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12. Read absorbances at 450 nm on a microplate reader (BioTek Instruments, Inc., VT, 
U.S.A. Model ELX 808U). 
Cell Density and Viability Measurement 
A widely used type of counting chamber known as hemacytometer was used to quanti-
tatively determine the viable cell concentration and the cell viability of culture samples. 
The following protocol was used with a Neubauer rulings hemacytometer: 
1. Carefully clean the mirror-like polished surface and coverslip using a 70% v/v ethanol 
aqueous solution. Place coverslip on the chamber prior to introducing the sample. 
2. Prepare the sample so that it contains one part culture sample and four parts 10% 
v/v trypan blue aqueous solution. The latter is used to colour the dead cells in the 
sample blue so as to distinguish them from the live cells, in a technique known as 
dye exclusion. 
3. Put the sample into one of the wells using a pipette, filling the area under the 
coverslip so that the mirrored surface is just covered. 
4. Place hemacytometer on the microscope stage and bring counting grid into focus at 
10 x magnification. 
5. Count number of viable and dead cells in the middle and the four corner large squares 
of the central area of the counting grid. 
6. To get the final count in cells/ml, divide the result by the total surface area counted 
(each square has a surface area of 1 mrn 2 and depth of 0.1mm). In this work, the 
cell density (in 10 4 cells/ml) is given by: 
cell density = 
cell count * dilution 
surface area of cell count 
3.3.4 Statistics 
Batch cultures were performed in triplicate and fed-batch in duplicate experiments. The 
experimental data reported in chapters 4 and 6 are the means of the experimentally 
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measured values. By definition, the algebraic sum of the deviations of a set of numbers 
from their arithmetic mean is zero (Spiegel and Stephens, 1999). Also reported are the 
standard errors of these mean values. The standard error is the standard deviation of the 
sampling distribution of those values and it reflects how much fluctuation the values will 
show. Statistical analysis was carried out using SigmaPlot8.0 (SPSS, Inc., Chicago, IL). 
3.4 Discussion 
The proposed model for cell growth and death, cell metabolism, protein synthesis and 
production, and protein glycosylation was presented in this chapter. Its novelty lies in 
the fact that it successfully couples cell metabolism with cell growth and antibody syn-
thesis, while remaining computationally tractable. Techniques for analysis of parameter 
properties were reviewed and the Sobol' method for global sensitivity analysis used in 
this thesis was described, followed by an overview of methods for optimal experimental 
design. Finally, the techniques and protocols employed for cell culture experimentation 
were defined and described. 
Chapter 4 
Model Simulation Results 
The mathematical model presented in Chapter 3 was simulated in gPROMS (Process Sys-
tems Enterprise Ltd, 2002a) for batch culture conditions and the results are compared with 
experimental data from triplicate experiments in order to validate the model structure. 
Moreover, estimates for parameter values are determined for the hybridoma cell system 
under investigation. 
4.1 Cell growth, metabolism and MAb production 
Experimental data for nutrients, metabolites, cell viability and MAb production were used 
to generate estimates for model parameters for the HFN 7.1 hybridoma cell line, as seen in 
Table 4.1. Figures 4.1 to 4.3 show that the model simulation results are in good agreement 
with the in vitro results for the case of batch culture operation. Glucose and lactate 
profiles are correctly predicted by the proposed model (figure 4.1), with model results 'being 
consistent with experimental data for all growth phases. The cells use up glucose slowly 
during the initial lag phase, until about 20 hours when they start rapidly catabolising the 
nutrient as they enter the exponential growth phase. The model predicts that glucose 
and lactate reach their final values at the time viable cells reach their peak concentration, 
which is slightly earlier than experimentally observed. The final concentrations of glucose 
and lactate are both correctly predicted. 
Similarly, glutamine and ammonia concentration profiles are successfully simulated 
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Table 4.1: Parameter values for cell growth, metabolism and MAb production model for 
batch cultures. 
Parameter Value 
K 10-1  
KA 10-6  
Kd,amm 1.759 
Kd,g171 9.6 x 10-3  
KER 6.93 x 10-1  
KG 1.386 x 10-1  
K9/, 7.5 x 10-1  
KgIn 7.5 x 10-2  
Klamm  28.484 
Khae 171.756 
Klysis 5.511 x 10-2  
1141, 4.853 x 10-14 
77, 2 
NH 1.398 x 102 
NL 1.175 x 102 
SR 3 x 103 
SL 4.5 x 103  
TH 17 
TL  11.5 
Yamm,gln 0.4269 
Ylac,gic 1.399 
Yx,gle 1.061 x 108 
Yx,gln 5.565 x 108 
continued on next page 
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continued from previous page 
Parameter Value 
al 3.4 x 10-13  
Ct2 4 
71 Er' 
"72 2 
€1 9.95 x 10-1  
€2 1 
PcOnax 3 x 10-2  
Amax 5.801 x 10-2  
(figure 4.2). There is some discrepancy between model results and experimental data in 
the case of glutamine concentration in the beginning of the culture. Between 0 and 30 
hours the model underpredicts the concentration of glutamine but remains within 15% 
of the experimentally observed values. During the remainder of the culture glutamine 
concentration is correctly predicted. Furthermore, predictions for ammonia concentration 
are consistent with the data throughout the duration of the experiment. 
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Figure 4.1: Comparison of model predictions to experimental data for glucose and lactate 
concentrations from batch HFN 7.1 cultures. 
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Figure 4.2: Comparison of model predictions to experimental data for glutamine and 
ammonia concentrations from batch HFN 7.1 cultures. 
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Figure 4.3: Comparison of model predictions to experimental data for viable cell concen-
tration from batch HFN 7.1 cultures. 
The successful prediction of nutrient and metabolite profiles leads to a good represen-
tation of the viable cell concentration (figure 4.3). The model captures its trend during 
the initial lag phase and correctly predicts the height and time of the peak in the number 
of viable cells. Model results predict higher concentrations during the exponential growth 
phase, but the overall experimental trend is observed. Similarly, during the decline of 
the viable cell concentration the model correctly captures the shape of the concentration 
profile and, in most cases, provides an accurate prediction of the viable cell number. 
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Figure 4.4: Comparison of model predictions to experimental data for extracellular MAb 
concentration from batch HFN 7.1 cultures. 
Finally, the profile of MAb concentration is also accurately simulated as shown in 
figure 4.4. The initial MAb concentration used for model simulation was 80mg/L, as 
there always are antibodies carried into the new culture through the inoculum. Model 
results correctly predict MAb concentration during the first 40 hours of the culture, but 
underpredict it during the peak in viable cell concentration and subsequent times, until 
the final concentration is reached. The latter is successfully determined by the model. 
4.2. 	Protein glycosylation 58 
Table 4.2: Spatial distribution of enzymes (Umana and Bailey, 1997). 
Enzyme Value 
For all enzymes except GaIT 
ek,i 0.15 
ek,2 0.45 
ek,3 0.30 
ek,4 0.10 
For GaIT 
ek,i 0 
ek,2 0.05 
ek,3 0.20 
ek,4 0.75 
4.2 Protein glycosylation 
Following the successful linkage of the unstructured and structured sections of the model, 
the glycosylation model was coupled using equations 3.29 and 3.33. The combined model 
was then simulated using the parameter values suggested by Umana and Bailey (1997) 
for glycoform biosynthesis, which can be found in tables 4.2 and 4.3. A total volume 
of the Golgi apparatus of 10gm 3, equally divided into the four compartments, was used 
for the simulations. It should be noted that these values were estimated from literature 
information for Chinese hamster ovary (CHO) cells, as such information is not available 
for hybridoma cells. However the model is still applicable, as it has been developed for 
glycoform biosynthesis in mammalian cells in general. Moreover, parameter values for 
hybridomas are expected to be similar to those used in this thesis, as CHO cells also 
produce and glycosylate MAbs (Jefferis, 2001). 
The compartmental nature of the Golgi apparatus was implemented in gPROMS 
(Process Systems Enterprise Ltd, 2002a) in the form of four continuous stirred tank re-
actors in series, each reactor representing a separate compartment. This configuration 
facilitates the flow of information, such as protein transport rates and exit oligosaccharide 
molar fractions, from one compartment to the next. Figure 4.5 shows typical dynamic 
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Table 4.3: Kinetic parameters for enzyme-catalysed reactions (Umana and Bailey, 1997). 
Reaction Km 
(AM- ) 
Vm,k 
(prno1/10 6cells/h) 
Reaction Km 
(AM) 
Vm,k 
(pmo1/10 6 cells/h) 
1 100 300 18 50 580 
2 100 300 19 40 580 
3 100 300 20 4000 4000 
4 100 300 21 4000 4000 
5 260 450 22 4000 4000 
6 200 300 23 190 4000 
7 100 300 24 190 4000 
8 190 140 25 190 4000 
9 130 10 26 190 4000 
10 3400 10 27 4000 580 
11 3400 10 28 4000 580 
12 90 10 29 4000 580 
13 4000 580 30 500 580 
14 4000 580 31 220 580 
15 4000 580 32 200 580 
16 130 580 33 140 580 
17 70 580 
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Figure 4.5: Dynamic results for reactant oligosaccharide (M9) molar fraction in the four 
compartments of the Golgi apparatus. 
profiles for the molar fractions of a reactant oligosaccharide (NI9) on the glycoprotein for 
the four compartments of the Golgi apparatus. This is assumed to be added to the protein 
in the ER, and is further added in the Golgi apparatus, where it also reacts to give rise to 
lower mannose structures. Intermediate oligosaccharide profiles are shown in figures 4.6 
and 4.7 for M6 and M3GnGn b , respectively. Again, these oligosaccharides are added to 
the protein and then react to yield other structures, mainly in the first two Golgi com-
partments. The dynamic profile of a "product" oligosaccharide (M3Gn4Gn bG) according 
to the CRN can be seen in figure 4.8. To my knowledge, these results represent some of 
the first reported dynamic results for glycosylation in the Golgi apparatus. 
The results show that the oligosaccharide molar fractions vary dramatically along the 
duration of a culture. This can be attributed to the differences in nutrient concentration 
encountered in the various culture phases and is in agreement with experimental observa-
tions by Tachibana et al. (1994); Nyberg et al. (1999), who report that protein oligosac-
charide content, and possibly protein bioactivity, depend on nutrient availability. It is 
currently not possible to validate the proposed model clue to lack of analytical techniques 
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Figure 4.6: Dynamic results for intermediate oligosaccharide (M6) molar fraction in the 
four compartments of the Golgi apparatus. 
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Figure 4.7: Dynamic results for intermediate oligosaccharide (11/13GnGn b) molar fraction 
in the four compartments of the Golgi apparatus. 
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Figure 4.8: Dynamic results for product oligosaccharide (1113Gn4Gn b G) molar fraction in 
the four compartments of the Golgi apparatus. 
for obtaining dynamic intracellular glycosylation data. Moreover, there arc no detailed 
oligosaccharide composition results for secreted MAbs available yet in the relevant litera-
ture. If glycosylation parameters can be determined specifically for MAb production from 
hybridoma cells and additional information on the dependence of MAb functionality on 
oligosaccharide molar fractions is provided, determination of the glycosylation efficiency 
factors, ei and E2, could become possible. 
4.3 Conclusions 
The good agreement of the simulation results with the experimental data for nutrient, 
metabolite, viable cell, and product concentrations confirms that the proposed model 
structure is applicable to the culture system investigated experimentally. The model is 
therefore a suitable basis for the design of optimal experiments that will determine its 
range of validity and investigate its predictive capabilities under fed-batch culture oper-
ation. Since all sections of this model were developed for different hybridoma cell lines, 
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these findings show that there is scope for developing a generic model of hybridoma cell 
cultures. Finally, the dynamic results of protein glycosylation, which are some of the first 
reported in the relevant literature, follow the expected trends. Even though this part of 
the model cannot be validated with existing experimental techniques, model predictions 
for glycosylation dependence on nutrient availability are in accordance with experimental 
observations. It can be concluded that the successful linkage of the unstructured expres-
sions for cell population dynamics and cell metabolism with the structured model for 
MAb production and the compartmental model for protein glycosylation paves the way 
for monitoring protein glycosylation. 
Chapter 5 
Parameter Sensitivity Analysis 
Results 
The Sobol' method for global sensitivity analysis was used to quantitatively assess the 
impact of individual model parameters as well as that of their first order interactions on 
model output, i.e. the extracellular concentration of monoclonal antibodies (MAN). The 
aim of the analysis was to identify the most sensitive parameters and the most informative 
time points of a culture in an effort to reduce the parameter set that requires accurate 
estimation from experimental data and to provide guidelines for the experimental design. 
5.1 Analysis and Results 
Model parameters were examined within a range of +100% of their nominal values as 
shown in table 4.1, including all previously reported values (Portner and Schafer, 1996), 
unless their physiological range of values was available from the literature (Bibila, 1991; 
Dorai and Moore, 1987; Schibler et al., 1978). Each parameter space was sampled using 
a Sobol' sequence. This is a quasi-Monte Carlo sampling method characterised by an 
advantageous property in that the generated sequence's projection onto any direction 
yields no overlapping points (Saltelli et al., 2000). It should be noted that the section of 
the model describing protein glycosylation was excluded from this analysis as it could not 
be experimentally validated at our laboratory. 
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Since it was not computationally efficient to examine all parameters at the same time 
(a minimum of 21 days would be required for each time point on a 2.4 GHz Pentium 
4, 512 Mb RAM), the less significant ones were identified and grouped in order to be 
varied together. This grouping was done iteratively and was initially based on results 
at the simulation time point of 20 hours, which represents the early exponential phase. 
It should, therefore, be a good indicator of the magnitude of the parameter sensitivity 
indices. The 16 grouped parameters were studied along with the remaining 14 individual 
parameters. 
The analysis was carried out at various model simulation times, equivalent to culture 
time points, to capture the dynamic behaviour of the individual and the total sensitivity 
indices (figure 5.1 with parameters numbered as in table 5.1). The chosen simulation times 
were 10, 20, 30, 40, 60, 70, 80, 90, and 100 hours. The time point corresponding to 10 
hours represents the lag phase, 20, 30, 40, and 60 hours the exponential cell growth phase, 
and 70 and 80 hours the peak in viable cell concentration. Finally, 90 and 100 hours 
represent the period of decline in cell viability. These time points were chosen based on 
sampling strategies widely accepted by experimentalists in this area, according to which 
most data for parameter estimation are collected during the exponential growth phase. 
The significance of each parameter was determined by ranking the averages of their 
sensitivity indices over the nine time points. If we consider 1% to be the minimum ex-
perimental error, then only parameters El , €2, 72 , Kd,gin , Ka, and the most sensitive of 
the grouped parameters have a measurable effect on model output as can be seen in table 
5.1. It should, therefore, theoretically be easier to estimate their values even though their 
identifiability is not guaranteed. As the sensitivity indices of the remaining parameters 
become smaller, estimation becomes more difficult. 
The dynamics of the sensitivity analysis results show that the glycosylation efficiency 
factors, ci and E2 (figures 5.1 and 5.2), remain important at all simulation times, i.e., 
throughout the duration of the cell culture. This can be attributed to their structural 
significance in that they are present in the final equations of the model and are propor-
tional to MAb concentration independently of the cell growth phase. However, it is also 
supported by the underlying biology as only the correctly glycosylated MAbs exit the 
cell. Glycosylation efficiency is therefore crucial for MAb secretion into the extracellular 
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Time point 
Figure 5.1: Variation of individual parameter global sensitivity indices with simulated 
culture time. 
Table 5.1: Parameter sensitivity indices as resulting from the global sensitivity analysis 
results averaged over the nine time points examined. 
Parameter Average sensitivity index Parameter Average sensitivity index 
(1) -y2 1.061 x 10-1  (9) NH 2.030 x 10-3  
(2) El 1.286 x 10-1  (10) K 1.540 x 10-3  
(3) 62 1.008 x 10-1  (11) SL 1.130 x 10-3  
(4) Kd,gln 7.398 x 10-2  (12) KA 7.3000 x i0-4 
(5) Group 2.831 x 10-2  (13) 3.200 x 10-4 
(6) KG 1.290 x 10-2  (14) -yi 9.000 x 10-5  
(7) KER 9.040 x 10-3  (15) /V.i, 2.000 x 10-5  
(8) SH 2.170 x 10-3 
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Figure 5.2: Variation of individual sensitivity index (II) and interaction contributions (0) 
for parameter Ei with simulated culture time. 
medium. Similarly, the constant for MAb production, 'y2, remains above the 1% thresh-
old at all times (figure 5.3), signifying the importance of this parameter. Nevertheless, 
the sensitivity indices of all three aforementioned parameters decrease with simulation 
time, since at later stages of the culture limited nutrient availability and, finally, nutrient 
deprivation cause growth-related parameters to become dominant. 
As shown in figure 5.4, the contribution of KG is significant only in the initial lag 
phase, during which viable cell concentration is still relatively low and thus parameters on 
the MAb synthesis pathway control MAb secretion. In contrast, Kd ,gln becomes important 
from the exponential phase onward when glutamine is rapidly being consumed by the cells 
causing its concentration to reach near-zero values after approximately 70 hours (figure 
5.5). The depletion of this primary nutrient subsequently becomes a limiting factor for 
cell growth and, therefore, for MAb production. 
The group of parameters initially regarded as less important is shown to have a sig-
nificant impact on the model output during the exponential growth phase. This is in 
agreement with the fact that the majority of the grouped parameters are those in the 
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Figure 5.3: Variation of individual sensitivity index (E) and interaction contributions (11) 
for parameter •-y2 with simulated culture time. 
Figure 5.4: Variation of individual sensitivity index (IC and interaction contributions (El) 
for parameter KG with simulated culture time. 
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Figure 5.5: Variation of individual sensitivity index for parameter Kd,girt  (CI) with simu-
lated culture time and glutamine concentration (-). 
cell metabolism, cell growth and death sections of the model, which become increasingly 
significant during the exponential phase. The reason for not capturing this when the pa-
rameters where grouped together is because their sensitivity was initially computed at the 
time of 20 hours, at which their collective contribution was indeed low. Further iterations 
showed that out of the 16 parameters in the group only K.1„,,„, Kime , and 	have 
a considerable impact. Since they are involved in growth inhibition due to metabolite 
build-up in the culture medium, their impact on cell viability, and thus production, be-
comes significant after the first 30 hours of the culture. The remaining parameters are 
characterised by low sensitivity indices throughout the simulated culture. Similarly, cer-
tain individually examined parameters such as p.max and S11 were found to have negligible 
effect on model output as seen in figures 5.6 and 5.7, respectively, but can contribute 
significantly to its value through their interactions with other parameters. 
The ratio of individual to total sensitivity indices reveals a significant degree of interac-
tion between the parameters. However, it is not possible to identify between exactly which 
parameters these interactions take place. Figures 5.2, 5.3 and 5.4 show that individual 
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Figure 5.7: Variation of individual sensitivity index (II) and interaction contributions (0) 
for parameter SH with simulated culture time. 
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sensitivity indices account for only a fraction of the total sensitivity of the parameters. For 
example, the highest individual index exhibited by KG is 0.042 (10 hours). At the same 
time point, the total index of KG is 0.105, meaning that the interactions of KG with other 
parameters on model output are responsible for more than half of the total contribution of 
this parameter (figure 5.4). Therefore, for such highly interacting parameters uniqueness 
of estimates cannot be guaranteed since a change in one parameter may be compensated 
by altering the value of another parameter (Versyck et al., 1997). Parameters '72, €1, and 
E2, on the other hand, which exhibit high sensitivity indices throughout the culture can, 
in theory, be estimated from any data, with preference to time points where the contribu-
tion of interactions is lowest. The remaining, less sensitive parameters can be set at their 
nominal values, as they do not significantly affect the model output. 
Finally, global sensitivity analysis was also carried out for the case of fed-batch biore-
actor operation. The three inputs, namely the inlet flow rate, F2„, and the inlet nutri-
ent concentrations, [GLC]in and [GLAT]„„ were set at their nominal values (Asprey and 
Mantalaris, 2001) and the analysis was repeated. Results highlighted the same model 
parameters as the most sensitive ones, showing that manipulation of the model inputs 
does not significantly alter parameter sensitivities. An example can be seen in figure 5.8, 
which shows the results for the same parameter grouping at the simulation time of 20 
hours. Parameters €1, €2, and 'Y2 have the highest sensitivity indices, followed by para-
meters KG and KER. Kd ,g in has a smaller impact as glutamine is still abundant in the 
culture medium and the grouped parameters have a countable yet less strong effect as the 
cells are predicted to be in the beginning of the exponential growth phase. The remaining 
parameters appear to have a negligible effect. These findings are of particular importance 
since it is fed-batch experiments that were designed for increasing parameter accuracy. 
The individual and total sensitivity indices reported here are reasonably precise, since 
they do not alter significantly as sample size increases as shown in figure 5.9. According 
to Saltelli et al. (2000) this is a sign that the index estimates have converged to their 
analytical values. 
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5.2 Conclusions 
The Sobol' method for global sensitivity analysis was applied to the model parameters 
in order to determine those that critically influence MAb concentration. The results 
identified 8 significant model parameters that need to be accurately determined from 
experimental data. The values of the remaining 22 parameters of the model have little 
effect on MAb concentration and can, therefore, be set at their nominal values. Overall, 
the results verified the consistency of the analysis with the underlying biology and provided 
indications for the most informative sampling times, which can be used as initial guesses 
in experimental design for accurate parameter estimation. 
Chapter 6 
Experimental Design Results 
The model developed has been shown to be accurate for the case of batch culture operation 
(Chapter 4). However, as most such industrial processes are operated in fed-batch mode, 
the goal of this work is to extend the model's predictive capabilities to fed-batch condi-
tions, so that it can be used for in silico experimentation, for designing appropriate control 
and optimisation strategies and for industrially-relevant applications in general. Assum-
ing that the model structure is applicable under such conditions, the specific objective 
is to accurately estimate the significant model parameters from fed-batch experimental 
data. As previous studies have discussed (Versyck et al., 1997; Nathanson and Saidel, 
1985; Munack and Posten, 1989), optimal experimental design uses the model to design 
sufficiently informative experiments for this purpose. It was therefo.c. employed in this 
work to increase the reliability of the model under fed-batch conditions. 
6.1 Experimental Design and Parameter Estimation 
The set of parameters targeted by the experimental design was different from that iden-
tified from the results of the global sensitivity analysis. This is because the analysis only 
considered MAb concentration as the output, but the experiments yielded data for cell, 
nutrient and metabolite concentrations as well. Since a full map of sensitivity indices 
with respect to all measured variables was not available, a brief qualitative one-at-a-time 
screening was carried out to identify the most influential parameters. Those were found 
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to be YX,g/„, Yx,g1n, Ylac,g1c, Yamm,gin, Kjusis , limos , and NH. Parameters Ei and E2 were 
not included in the design as glycosylation data were not available and parameter -y2 was 
not re-estimated as it is closely linked with the cells' position in the cell cycle, for which 
no analysis was carried out. 
In fed-batch cultures concentrated medium is supplied to the culture vessel, in this case 
in pulses. The concentrations of glucose and glutamine in the feed were set at 500mM 
and 100mM, respectively. The maximum total volume of feed was fixed at 8.75m1, which 
represents nearly 5% of the total culture volume (200m1), so as to avoid dilution effects. 
The amount of feed supplied at each feeding interval and the timing of the intervals were 
optimised by the design. Sampling times, at which viable and total cell, MAb, and glucose, 
glutamine, lactate, and ammonia concentrations were determined, were set a priori and 
can be found in table 6.1. Finally, the optimal duration of the experiment was determined 
by the design at 168 hours (7 days), during which a pulse feed was introduced once a day. 
The experiment was designed with the relevant function (experiment design for parame-
ter precision) of gPR,OMS, which uses a SRQPD sequential quadratic programming code 
(Process Systems Enterprise Ltd, 2002b), and the results can be found in table 6.1. 
Fed-batch cultures of HFN 7.1 hybridoma cells were performed accordingly in du-
plicates and the generated data were used to re-estimate the parameter values for the 
fed-batch operation mode in gEST, which employs a SRQPD sequential quadratic pro-
gramming code (Process Systems Enterprise Ltd, 2002b). The results of the estimation 
of the 7 aforementioned parameters are shown in table 6.2 and the complete set of para-
meter values for fed-batch cultures can be seen in table 6.3. The confidence intervals of 
the estimated parameters are satisfactory, with the 95% confidence intervals lying within 
±10% of the final value for all parameters except Yamm ,.gin (±17%). 
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Table 6.1: Schedule of designed fed-batch experiment. 
Sampling time Feed volume Sampling time Feed volume 
(ml) 
	
(hr) 	(ml) 
90 
feed : 12.1 	1.25 	 96 
18 	 108 
24 	 feed : 108.1 	1.25 
36 	 114 
feed : 36.1 	1.25 	 120 
42 	 132 
48 	 feed : 132.1 	1.25 
60 	 138 
feed : 60.1 	1.25 	 144 
66 	 156 
72 	 feed : 156.1 	1.25 
84 	 162 
feed : 84.1 	1.25 	 168 
(hr) 
12 
Table 6.2: Parameter estimation results for fed-batch culture. 
Parameter Value 90% 
Confidence Intervals 
95% 99% 
Yx,gle 2.6 x 10 8 2.224 x 10 7  2.654 x 10 7  3.494 x 10 7 
Yx,gln 8 x 10 8 2.134 x 10 7  2.546 x 10 7  3.352 x 10 7 
Yac,glc 2.033 0.1768 0.2109 0.2777 
Yainm,gln 0.4519 0.06564 0.07832 0.1031 
-K1y8z8 0.3014 0.00252 0.003007 0.003959 
!Amax 0.05439 0.0008306 0.0009909 0.001305 
NH 101 5.067 6.045 7.959 
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Table 6.3: Parameter values for cell growth, metabolism and MAb production model for 
fed-batch cultures. 
Parameter Value 
K 10-1  
K A 10-6 
Kd,amm 1.759 
Kd,gln 9.6 x 10-3  
K ER 6.93 x 10-1  
KG 1.386 x 10-1  
Kg ie  7.5 x 10-1  
K gln 7.5 x 10-2  
K iarnrn 28.484 
Kitac 171.756 
Klysis 3.014 x 10-2  
Mgt, 4.853 x 10-14 
n 2 
NH 1.01 X 102  
Nj 1.025 x 102 
SH 3 x 103 
Si, 4.5 x 103 
Tjj 17 
TL 11.5 
Yarnm,gin 2.033 
Ylac,gle 0.4519 
Ys,gle 2.6 x 108 
Yx,gln 8 x 108 
continued on next page 
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continued from previous page 
Parameter Value 
al 3.4 x 10-13  
a2 4 
'yl 10--,  
72 2 
El 9.95 x 10-1  
E2 1 
ild,max 3 x 10-2  
Amax 5.439 x 10-2  
The resulting model is in good agreement with the results of this first experiment 
as shown in figures 6.1 to 6.5. More specifically, glucose concentration is marginally 
overpredicted during the initial few hours of the culture, with the remaining experimental 
data closely tracked by the model (figure 6.1). Overall, the profile of glucose concentration 
is correctly predicted by the model. Similarly, lactate concentration is underpredicted in 
the first 50 hours, as glucose consumption is higher in vitro than in silico. From the time 
point of 60 hours onwards lactate is accurately predicted by the model. Compared with 
the batch experiments, glucose concentration remains at higher levels, not falling below 
15 mM, as a result of the frequent addition of glucose-rich medium. The final lactate 
concentration is also significantly higher than that in the batch cultures, almost reaching 
40 mM (27 mM in batch cultures), as the increased metabolism of glucose led to higher 
cell concentrations. 
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Figure 6.1: Comparison of model predictions to experimental data for glucose and lactate 
concentrations from designed fed-batch experiment. 
Figure 6.2 shows the good agreement between model simulation results and experi-
mental data for glutamine and ammonia. Glutamine concentration is correctly predicted 
throughout the duration of the culture. Discrepancies only occur once glutamine has 
reached zero concentration (after 80 hours), when additional glutamine fed to the culture 
is metabolised more quickly than predicted. Ammonia concentration is also closely tracked 
by model results. It is correctly predicted during the initial lag phase, overpredicted over 
the following 70 hours, and closely matched during the remainder of the culture. Gluta-
mine is exhausted later on in the fed-batch culture (80 hours) compared with the batch 
culture (60 hours), as the additions of medium boost its concentration during the early 
hours of the culture. The degree of ammonia accumulation is similar to that in the batch 
culture for the first 60 hours, but increased glutamine metabolism in the fed-batch culture 
results in higher ammonia concentrations after that (5.2 mM in fed-batch compared to 3.4 
mM in batch). 
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Figure 6.2: Comparison of model predictions to experimental data for glutamine and 
ammonia concentrations from designed fed-batch experiment. 
Predictions and experimental data for viable and total cell concentrations can be seen 
in figures 6.3 and 6.4, respectively. Simulation results for viable cell concentration closely 
match the data during the first 60 hours. Thereafter, model predictions follow the trend 
of the experimental data correctly predicting the two peaks in viable cell concentration. 
Over the last 40 hours the model overpredicts the concentration of viable cells in the 
culture. This is probably because the viable cell concentration in vitro is too low for 
the cells to recover viability, but the model predicts that will occur as more concentrated 
feed is supplied to the culture. The data for total cell concentration are more accurately 
matched by the simulation results (figure 6.4). Again, there is good agreement over the 
first 100 hours, with few discrepancies thereafter. The overall trend of the concentration 
is correctly captured by the model. The results show a significant increase in viable cell 
concentration compared to the batch culture data (2.12 x 10 9 in fed-batch compared to 
1.36 x 10 9 in batch), which is in agreement with reported experimental observations (Zhou 
et al., 1995; Yang et al., 2000; Sauer et al., 2000) and is one of the main reasons for using 
fed-batch cultures industrially. Moreover, high concentrations are maintained for longer, 
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Figure 6.3: Comparison of model predictions to experimental data for viable cell concen-
tration from designed fed-batch experiment. 
as the introduction of concentrated medium boosts cell numbers. 
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Figure 6.4: Comparison of model predictions to experimental data for total cell concen-
tration from designed fed-batch experiment. 
Finally, model simulation results for extracellular MAb concentration are in good agree-
ment with experimental data as shown in figure 6.5. The model closely tracks the data 
throughout the duration of the culture, correctly predicting the MAb concentration during 
the lag and exponential growth phases, as well as the final concentration in the medium. 
Overall, the model captures the profiles of all measure variables successfully. The final 
MAb concentration is considerably higher in fed-batch cultures, reaching almost 2.5 g/L 
compared to 1.2 g/L in batch cultures. The addition of concentrated feed and the subse-
quent increase in viable cell concentration thus significantly enhanced MAb concentration, 
in accordance with previous reports (Bibila and Robinson, 1995; Sauer et al., 2000). 
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Figure 6.5: Comparison of model predictions to experimental data for extracellular MAb 
concentration from designed fed-batch experiment. 
6.2 Predictive Experiment 
In order to demonstrate the model's predictive capability, its simulation results were com-
pared with an independent set of data from a fed-batch experiment, the schedule of which 
is shown in table 6.4. The initial glucose and glutamine concentrations were lower than 
in the designed experiment and the same amount of concentrated feed was introduced 
but in two instead of one doses per day. The sampling schedule was the same as in the 
designed experiment, with viable and total cell, nutrient, metabolite, and extracellular 
MAb concentrations determined at each point. 
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Table 6.4: Schedule of predictive fed-batch experiment. 
Sampling time 
(hr) 
Feed volume 
(ml) 
Sampling time 
(hr) 
Feed volume 
(ml) 
12 90 
feed : 12.1 0.625 96 
18 feed : 96.1 0.625 
24 108 
feed : 24.1 0.625 feed : 108.1 0.625 
36 114 
feed : 36.1 0.625 120 
42 feed : 120.1 0.625 
48 132 
feed : 48.1 0.625 feed : 132.1 0.625 
60 138 
feed : 60.1 0.625 144 
66 feed : 144.1 0.625 
72 156 
feed : 72.1 0.625 feed : 156.1 0.625 
84 162 
feed : 84.1 0.625 168 
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Figure 6.6 compares the simulation results with experimental data for glucose and 
lactate concentrations. It can be seen that the model overpredicts glucose concentration 
throughout the duration of the culture. This is consumed to a greater degree than in 
the designed fed-batch experiment, reaching final concentrations similar to those in the 
batch cultures. Lactate concentration is significantly underpredicted during the lag and 
initial exponential growth phases, because in its predictions the model takes into account 
a lower glucose consumption rate than that observed experimentally. Even though the 
overall trend is correct, the model only captures the concentration of lactate during the 
final 40 hours of the culture, when it reaches the same level as in the designed experiment. 
A possible reason for the lack of agreement between the predictions and the data is that, 
since concentrated feed is introduced more frequently but in smaller doses as compared to 
the previous fed-batch culture, the cells utilise glucose differently from the first experiment. 
The results imply that glucose metabolism is more efficient, as more glucose is consumed 
but less lactate is produced, a phenomenon also reported by Zhou et al. (1995); Zhang 
et al. (2004). Such a switch between different metabolic behaviours is not captured by 
the model, which could, therefore, not have predicted the experimental results with great 
accuracy. 
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Figure 6.6: Comparison of model predictions to experimental data for glucose and lactate 
concentrations from independent fed-batch experiment. 
Contrary to glucose and lactate, glutamine and ammonia concentrations are accurately 
predicted by the model as shown in figure 6.7. Simulation results closely track the ex-
perimental data for glutamine, with some discrepancies between 60 and 90 hours, when 
the predictions are marginally lower than the experimental values. Ammonia concentra-
tion data are also matched by model results. There are some small discrepancies between 
20 and 70 hours, when the predicted concentration is higher than observed, and during 
the final few hours of the culture, when the concentration is marginally underpredicted. 
Glutamine is again exhausted at a later stage and ammonia concentration reaches consid-
erably higher levels than in batch cultures, as was the case with the designed fed-batch 
experiment. 
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Figure 6.7: Comparison of model predictions to experimental data for glutamine and 
ammonia concentrations from independent fed-batch experiment. 
In terms of the cell concentrations, the trends of both viable and total cell profiles 
are predicted satisfactorily. The model closely tracks the data for viable cell concentra-
tion during the first 70 hours of the culture, correctly predicting the lag and exponential 
growth phases (figure 6.8). The in silico peak in concentration is lower than the in vitro, 
but subsequent predictions match the data. As in the case of the designed fed-batch ex-
periment, there are discrepancies in the final few hours of the culture, when the model 
predicts that the cells can recover their viability since more nutrients are supplied, but 
that is not observed experimentally. The total cell concentration is correctly predicted 
throughout the culture. There is good agreement between simulation results and exper-
imental data during the lag and exponential growth phases. The peak in concentration 
is then predicted to be higher than that observed, after which the decline in cell number 
is closely tracked by the model. Again, viable cell concentration is considerably higher in 
this fed-batch experiment than in the batch cultures. 
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Figure 6.8: Comparison of model predictions to experimental data for viable cell concen-
tration from independent fed-batch experiment. 
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Figure 6.9: Comparison of model predictions to experimental data for total cell concen-
tration from independent fed-batch experiment. 
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Figure 6.10: Comparison of model predictions to experimental data for extracellular MAb 
concentration from independent fed-batch experiment. 
Finally, results for extracellular MAb concentration can be seen in figure 6.10. The 
model correctly predicts the concentration during the first 30 hours of the culture, but then 
underpredicts it consistently nearly until the end of the culture, when the final concentra-
tion is correctly determined. One reason for this may be the fact that the peak in viable 
cell concentration is underpredicted by the model resulting in lower MAb concentrations 
in si/ico. Another reason could be that, due to the lower glucose concentration, more cells 
are arrested in the Go phase of the cell cycle. The latter has been associated with higher 
MAb productivity, a phenomenon that is not captured by the model. The results of this 
second fed-batch culture confirm that this operation mode significantly enhances MAb 
concentration, as the latter is double that observed in hatch experiments. Overall, based 
on the level of biological information that is described by the existing model structure, 
the agreement between simulation results and experimental data from the independent 
fed-batch experiment is satisfactory. 
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6.3 Conclusions 
The above results demonstrate that a hybrid, structured/unstructured model can, in gen-
eral, correctly predict the profiles of nutrients, metabolites, cell and product concentra-
tions under fed-batch culture conditions. These findings show that, following a systematic 
framework for model analysis and experimental design, it is possible to improve the re-
liability of simple, unstructured or hybrid, models of animal cell cultures and to extend 
their range of applicability. Previous applications of optimal experimental design in this 
field were restricted to simpler systems of microorganisms (Bernaerts et al., 2000) and 
were often incomplete, as parameter estimation was performed using simulated results 
(Versyck et al., 1997). To my knowledge, this is one of the first attempts to close the 
loop between model-based tools and designed experimentation in biological systems and 
to formalise the steps of the model development process for animal cell cultures, avoiding 
trial-and-error practices and, thus, unnecessary experimentation. 
Chapter 7 
Amino Acid Metabolism 
Amino acids have long been identified as key nutritional factors of animal cell cultures, 
with demonstrated effects on cell growth and protein productivity (Duval et al., 1991; 
Sanfeliu et al., 1996; Doverskog et al., 1997; Simpson et al., 1998). A recent study on 
hybridoma cells showed that deprivation of any single amino acid leads to apoptotic cell 
death (Simpson et al., 1998), but the importance of each amino acid with respect to 
enhancing cell growth is reported to be cell line specific (Duval et al., 1991). Amino acids 
have however largely been excluded from mathematical model of cell cultures, with the 
exception of very few studies such as those by Silva et al. (1996) and Sanderson et al. 
(1999). A possible reason for this is the difficulty of obtaining amino acid data either 
from literature or from actual experiments, the latter due to the high cost of relevant 
measurements and equipment. The incorporation of amino acid metabolism in cell culture 
models is, therefore, a necessary but challenging task. The proposed model examines 
the relation of 19 amino acids (excluding tryptophan) and glucose with cell growth of 
human embryonic kidney (HEK-293) cells and is also found to be applicable to interferon-y-
producing Chinese hamster ovaries cells (CHO-IFN-y). 
7.1 Mathematical Model 
The mathematical model describes cell growth kinetics and cell metabolism in an unstruc-
tured manner, but based on the underlying mechanisms of amino acid metabolism. The 
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Figure 7.1: Network of amino acid and glucose metabolism used for model development. 
network of amino acid and glucose metabolism used for model development is based on 
existing biological knowledge, as well as observed culture behaviour, and can be seen in 
figure 7.1. This network is in general agreement with literature sources (Stryer, 1995; 
Alberts et al., 2002) and the pathways available in the Kyoto Encyclopedia of Genes and 
Genomes (KEGG). 
The model is based on certain standard assumptions, such as well-mixed bioreactor 
and perfect control of pH and dissolved oxygen concentration at desired levels. The mito-
chondria, where the TCA cycle takes place, are treated as a black box. The cell itself is a 
semi-black box; intracellular amino acid concentrations are not considered, but extracel- 
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lular concentrations are determined according to the overall reactions that are known to 
take place within the cell. 
7.1.1 Cell growth kinetics 
The model considers two feed streams to the bioreactor, one that contains amino acids 
and another that supplies only glucose, and one outlet stream. The overall mass balance 
therefore is: 
dV 
dt 	
rin + r glc Fout, 	 (7.1) 
where, V is the culture volume (L), Fin, Fplc, and Fout are the amino acid inlet, glucose 
inlet, and outlet flowrates (L/h), respectively. A material balance for the viable cells 
within the bioreactor: 
d(V X„) 
dt 	
[IV — 	— FoutXu, = 
	 (7.2) 
where, Xi, is the viable cell concentration (cell/ L) and jt, /I d are the specific cell growth 
and death rates (h-1), respectively. A material balance for the dead cells in the bioreactor 
gives: 
dt 	 — KipsisVXd — FoutXd, 
where, Xd is the dead cell concentration in the bioreactor (cell/ L). Finally, the total 
number of cells in the bioreactor is: 
Xt 	+ Xd, 	 (7.4) 
where, Xi, is the total cell concentration (cell/L). 
The specific growth rate for mammalian cells is given by: 
(/'max — Rutin) [GLC] [GLN]  
= firrun (Kgie + [GLC])(Kgin [GLN]) 
[ASP][ARG][V AL][LY S][THR]  
(Karp +[ASP])(K„g [ARG])(K„i + [V AL]) (Ki ps + [LY S])(Kdir [THR]) 
[HIS] [SER] [ILE] [PHE] [LEU]  
(Khis +[1-1-rg)(Kser [SER])(Kiie + [ILE])(Kphe+ [PH E])(Kieu  + [LEU])' (7'5) 
d(VXd)  (7.3) 
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where, iLmin  and Amax are the minimum and maximum specific growth rates (h-1), re- 
spectively. Kgic , Kgia, Kasp, Karg , Kvai, 	Kthr, 	Kile, Kite, and Klee, are the 
Monod constants for glucose, glutamine, aspartate, arginine, valine, lysine, threonine, 
serine, isoleucine, phenylalanine, and leucine (mM), respectively, with [GLC], [GLN], 
[ASP], [ARC], [VAL], [LY S], [THR], [SER], [ILE], [PHE], [LEU] being their respec-
tive concentrations in the extracellular medium (mM )• 
Similarly, the specific cell death rate is determined by the following equation: 
[Al U 
Ltd = Prn d,as( 
Kd,amrn + 
M] 
[AMM]j 
) n 	1 	 (7.6) 
 
where, lid,max is the maximum specific death rate (h-1), and Kd,amm  is the constant for 
cell death by ammonia (mM). 
7.1.2 Amino acid metabolism 
The concentrations of the consumed and produced amino acids in the extracellular medium 
can be obtained by performing material balances on each one of them 
actor. Therefore, for alanine: 
dt 	— C2alaVXa + F
in [ALA] in — Fotit [ALA], 
around the biore- 
(7.7) d(V[ALA])  
where, [ALA], [ALA]in are the concentrations of alanine in the culture medium and the 
amino acid feed (mM), respectively, and Qaia is the specific rate of alanine production 
(mmollcelllh), which is given by: 
Q ala = 	ala,xXv, 	 (7.8) 
where, V-- x,ala is the yield of cells on alanine (celllmmol) and Yaia,x the yield of alanine on 
dt 	— QargVXv + Fin[ARG]in — Faut[ARG], 
Qarg = y 	 Yarg,gluQglu Yarg,proQpro Yarg,aspQasp, 
x,arg  
the cells (mmol/cell). 
Similarly, for arginine: 
d(V[ARG]) (7.9) 
(7.10) 
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where, [ARG]in is the arginine concentration in the amino acid feed (mM), Qarg is the 
specific rate of arginine consumption (mmol I cell I h), and Yx ,arg is the yield of cells on 
arginine (ce///mmo/). Y - arg,g1u, Yarg,pro, and  Yarg,asp  are the yields of arginine on gluta-
mate, proline, and aspartate (mmol Immo°, respectively. Finally, Q9/ „, C21,7.0 , and Qasp 
are the specific rates of glutamate and proline production and aspartate consumption 
(mmol/mmo/). 
For asparagine: 
dt 	 X — QasTY , + F
ni [ASN],„ — F„,t [ASN], 
Qasn = —Yasn,aspQasp, 
where, [ASN]in is the asparagine concentration in the amino acid feed (m1V1), Qasn  is the 
specific rate of asparagine production (mmol 'cell I h), and Y -asn,asp is the yield of asparagine 
on aspartate (mmol I mmol). 
For aspartate: 
dt 	= QaspVXv + Fin [ASP] in 
— F„„t [ASP], 
Qasp   Yasp,argQarg + Yasp,x Xv , 	 (7.14) 
x,asp 
where, [ASP]in is the concentration of aspartate in the amino acid feed (mM), Yx,asp and 
Yasp,x are the yields of cells on aspartate (cell Immol) and aspartate from cells (mmol I cell), 
respectively, and Y - asp,arg is the yield of aspartate on arginine (mmol I mmol). 
For cysteine: 
dt 	= QcysVXv 
Fin [CYS]jr, — Fout [CY S], 
Qcys — 	P 	Ycys,serQser, ,„ x,eys 
where, [GYM , [CYS]in are the medium and amino acid feed concentrations of cysteine 
(mM), respectively, Qey, and (2,„ are the specific rates of cysteine production and serine 
d(V[ASN]) (7.11) 
(7.12) 
d(V[ASP] ) (7.13) 
d(V[CY SD (7.15) 
(7.16) 
dt 	 -= Qg
tuVXv + Fin[GLU]in — Fout [GLU], 
d(V[GLU] ) (7.17) 
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consumption (mmol 'cell I h), and Y,,,y, and 116 s,ser are the yields of cells on cysteine 
(cell Imm,ol) and of cysteine on serine (mmo//mmo/), respectively. 
For glutamate: 
, -yr  
Qglu = 	 1 glu,proC2 pro —Yglu,hisQ his —Yglu,g1nQ gln — Yglu,argQ ar g +Yglu,xXv 7  (7.18) 
Y 	
1-
x,glu 
where, [Gan and [GLU]in are the medium and amino acid feed concentrations of glu-
tamate (mM), respectively, Qh7:8 and Qgir, are the histidine and glutamine specific con-
sumption rates (mmol I cell I h), respectively, and Yx,giu  is the yield of cells on glutamate 
(cell lmmol). Y - glu,prol Yglu,hi,s7 Yglu,g1n7 Ygtu,arg, and Y ghix are the yields of glutamate on 
proline, histidine, glutamine, arginine (mmo//mmo/) and cells (nimol I cell), respectively. 
For glutamine: 
dt 	— Q91nV Xv — Kci,
ginV[GLN] + Fzn [GLN] ii, — Fout [GLN], 	(7.19) 
Qgln — 	 Mgln Ygln,gluQglu7 , 
x,gln 
(7.20) 
Mgin = al 
[GLN]  (7.21) 
az + [GLN]' 
where, [GLN]i„ is the concentration of glutamine in the amino acid feed (mM), Yx,gln is 
the yield of cells on glutamine (cell Immol), Y—gi,,giu is the yield of glutamine on glutamate 
(mmo//mmo/), Mgin is the maintenance coefficient of glutamine (mmol/cell/h), and ai 
and a2 are the constants of glutamine maintenance coefficient (rtiM L I cell h and mM, 
respectively). 
For glycine: 
dt 	— (4107 
Xv + Fin [GLY]in — Fo„t[GLY], 
Qgly = —Ygly,serQser7 
d(V[GLN] 
d(V[GLY]) (7.22) 
(7.23) 
dt 	
— QzteVXv + Frn[I L 	— Fout [I L E] 
d(V[I LE]) (7.26) 
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where, [GLY] and [GLY]in are the medium and amino acid feed glycine concentrations 
(mM), Qgiy is the specific rate of glycine production (mmol I cell I h), and Y9iy,„7, is the 
yield of glycine on serine (mmol Immo°. 
For histidine: 
dt 	— C2hisVX, + Fin [-THS]in — Font [11/ 5], 
Qhis
7 
(7.25) 
x,his 
where, [HIS] and [H S] in are the concentrations of histidine in the medium and amino 
acid feed (mM), respectively, and Yx,his is the yield of cells on histidine (cell Immol). 
For isoleucine: 
d (V [H I SD (7.24) 
Qile =  	 (7.27) 
r x,i1e 7  
where, [1-LE]i„ is the isoleucine concentration in the amino acid feed (mM), Qite  is the 
specific rate of isoleucine consumption (mmol !cell I h), and Yx,ii, is the yield of cells on 
isoleucine (cell Immo°. 
For leucine: 
dt 	
— QleuV Xv Fiu[LEU]in Fout[LEU], 
(7.29) 
	
(hen — 	 
x,leu 7  
where, [LEU]in is the concentration of leucine in the amino acid feed (mM), Qieu is the 
specific rate of leucine consumption (mmol I cell I h), and Yx ,/,„ is the yield of cells on 
leucine (cell Immol). 
For lysine: 
dt 	— Qiy8VX, + F
in [LY S]in — Fout [LY S], 
d(V [LEU]) (7.28) 
d(V [LY S]) (7.30) 
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tt  
Y Q lys 	 ty s,x X v 	 (7.31) Yx,lys 
where, [LYS]2,, is the lysine concentration in the amino acid feed (mM), Qiy, is the specific 
rate of lysine consumption (mmol I cell I h), and -11- ,/ys and Ylys,x arc the yield of cells on 
lysine (cell I mmol) and that of lysine on cells (mmol I cell), respectively. 
For methionine: 
dt 	= QmetVXv + F
in [MET]in  — Foni [M ET], 
Q met =  	 (7.33) 
x ,met 
where, [MET] and [MET]in are the medium and amino acid feed concentrations of 
methionine (mM), respectively, Q met is the specific rate of methionine consumption 
(mmol / cell 111), and Yx,met is the yield of cells on methionine (cell I minol) 
For phenylalanine: 
d(V [P HE])  
= 	pileV Xv + Fin [P H E],n — Font [P H 	 (7.34) dt 
Qphe =  	 (7.35) 
x,phe 
where, [PH.E]in  is the phenylalanine concentration in the amino acid feed (mM), Qphe is 
the specific rate of phenylalanine consumption (mmol I cell I h), and Yx,phe is tile yield of 
cells on phenylalanine (cell I mmol). 
For proline: 
dt  = QproVX
v + Fin[PRO]in — Fout [PRO], 
Qpro = Ypro,gluCd glu Ypro,argQarg, 
Yx,pro 
where, [P R 0] and [P RO]in are the medium and amino acid feed proline concentrations 
(mM), Qpro is the specific rate of proline production (nun ol I cell I h), Yx ,pro is the yield of 
cells on proline (cell I mmol), and Ypro,,/u and Ypro,arg  are the yields of proline on glutamate 
and arginine (mmol/mmol), respectively. 
d(V [MET]) (7.32) 
d(V [P R0]) (7.36) 
(7.37) 
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For serine: 
dt 	QserV Xv 
Fin[SER]in — 
Qser — 1.1 .17  
1  T,Ser '  
where, [SER],„ is the serine concentration in the amino acid feed (mM) and 17,,,„ is the 
yield of cells on serine (cell Immol). 
For threonine: 
dt 	= C2thi-V Xv + Fin[T II 	
— Font [TH 17], 
11 	 (7.41) Qthr = 17x,thr ' 
where, [THR],in is the threonine concentration in the amino acid feed (m/1/), Qthr is the 
specific rate of threonine consumption (mmol I cell I h), and V _ x,thr is the yield of cells on 
threonine (cell I mmol). 
For tyrosine: 
d (V [TYR] 
dt 	= QtyrVXv + Fin[TYR]in — Th
ut [TY 
	 (7.42) 
Qtyr = 	 Ytyr,pheQphe, 	 (7.43) Yx ,tyr  
where, [TYR] and [TYR],„ are the concentrations of tyrosine in the culture medium and 
the amino acid feed (m,/V/), respectively, Qphe is the specific rate of tyrosine consumption 
(mmol I cell I h), Yx,tyr is the yield of cells on tyrosine (cell I mm ol), and Ytyr,phe is the yield 
of tyrosine on phenylalanine (mmo//mmo/). 
Finally, for valine: 
dt 	= QvalV Xv Fin[V 
AL]i,, — Fout [V AL], 
Qval 
It 
 
(7.45) 
Yx,val ' 
d(V[SER] ) (7.38) 
(7.39) 
d (V [T T-1 RD (7.40) 
d(V [V AL]) (7.44) 
d(V [LAC]) 
dt 	= QicieV Xv — Fout [LAC], (7.48) 
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where, [VAL] and [VAL]in are the valine concentrations in the medium and the amino 
acid feed (mM), Qva i is the specific rate of valine consumption (mmo//ce///h), and Y. - 
is the yield of cells on valine (cell Immol). 
7.1.3 Other metabolic activities 
Another key nutrient for the cells is glucose. The overall mass balance for glucose is: 
dt 	= CbleV + F
gle [GLC],n , — Fout [GLC], 
Qgic = 11 	Mglc, 	 (7.47) 
where, [GLC]in is the glucose inlet concentration (mM), Qg ic is the specific rate of glucose 
consumption (mmol I cell I h), and -17,,g ie is the yield of cells on glucose (cell Immo°. 
Glucose metabolism gives rise to an undesired by-product, namely lactate. Its concen-
tration and specific rate of production are given by: 
d(V[GLC] ) (7.46) 
Q lac 	—Yiac,gicQ glc, 
	 (7.49) 
where, [LAC] is the lactate concentration in the culture medium (mM), C2/„, is the specific 
rate of lactate production (wool I cell I h), and V,  - uac,glc is the yield of lactate on glucose 
(mmol I mrnol). 
Finally, glutamine metabolism also produces ammonia, the concentration of which is 
given by: 
dt 	= QamniVXv K d,ginV[G LAT] — Fout[AM 
	 (7.50) 
Qamm = —Yamm,glnQ 
	
(7.51) 
d(V[AMIVI] ) 
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where, [AM/V/] is the ammonia concentration in the culture medium (miff), Q„,,, is the 
specific rate of ammonia production (mmol/cell/h), and Y„,„,,,,,g/„ is the yield of ammonia 
on glutamine (mmol/mmol). 
7.2 Model simulation results 
The above model was simulated in gPROMS for batch culture conditions using the pa-
rameter values shown in Table 7.1, which were determined from the available data. The 
results were then compared to experimental data from two batch cultures (labeled 'batch 
1' and 'batch 2') of HEK-293 cells carried out by Yih Yean Lee at the Bioprocessing 
Technology Institute, A*Star, Singapore, and both can be seen in the following figures. 
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Table 7.1: Parameter values for amino acid metabolism model. 
Parameter Value Parameter Value 
Karg 2.5 x 10-2  Yglu,x 10-25  
Karp 10-1 Ylac,gle 1.2 
Kd,amm 15 Ylys,x 10-23 
K gic  3 x 10-2  Ypro,arg 1.2 
KgIn 3 x 10-3  Ypro,glu 1 
Khis 10-2  Yser,gly 10-1  
Kite 5 x 10-2  Ytyr,phe 1 
Klett 1.5 x 10-2  Yx,ala 1.5 x 108 
Ktp, 2 x 10-2  Yx,arg 4.6 x 109  
Klysis 1.3 x 10-2  Yx,asp 2.5 x 109 
Kphe 5 x 10-2  Yx,cys 2 x 109  
Ks„ 2.5 x 10-2  Yx,gle 1.4 x 108 
Kt hr 5 x 10-2  Yx,gln 4 x 108 
Kval 2.5 x 10-2  Yx,glu 4 x 109 
Mglc 4.854 x 10-14 .17 x,his 2.4 x 1010  
n 2.3 Yx,ile 6.85 x 109 
Yala,x 4 x 10-21  Yx,leu 2.5 x 109  
Yarnrn,gln 9.5 x 10-1  Yx,lys 6.3 x 109 
Yarg,asp 10-2  Yx,met 1.9 x 101° 
Yarg,glu 10-2  Yx,phe 1.4 x 1010  
Yarg,pro 10-2  Yx,pro 1011  
Yasn,asp 1.85 x 10-1  Yx,ser 1.35 x 109 
Yasp,arg 10-2 Yx,thr 1010 
Yasp,x 5 x 10-25  Yx,tyr 4.35 x 109 
continued on next page 
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continued from previous page 
Parameter Value Parameter Value 
Ycys,ser 1 Yx,val 6 x 109 
Ygln,glu 1 al 3.4 x 10-13  
Yght,arg 10
-3  a2 4 
Yglu,gln 2 x 10-1  itd,max 10-2 
Yglu,his 1 ihrtax 6.5 X 10-2  
Yglu,pro 
10-2 Patin 2.5 x 10-2  
Ygly,ser 4 x 10-1  
Figure 7.2 shows the agreement between model simulation results and experimental 
data for the viable and total cell concentrations for the first batch culture, while similar 
results were obtained for the second culture. The lag phase observed experimentally was 
not fully captured by the model, but both viable and total cell concentrations are pre-
dicted accurately during the exponential growth phase. It is not clear from the data when 
the peak in viable cell concentration occurs, especially because the nutrient concentrations 
reach their final values after viability has begun to decrease (figures 7.3 and 7.4). The 
model predicts the peak at approximately 70 hours and is in agreement with experimental 
results throughout the viability decline phase, apart from the results for 90 hours. Regard-
ing the total cell concentration, the simulation results closely track the experimental data 
except at 99 and 114 hours. These two points exhibit a sharp drop in the concentration, 
which is not supported by the following point at 140 hours. 
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Figure 7.2: Comparison of model predictions to experimental data for viable and total cell 
concentrations from a batch HEK-293 culture. 
Results for glutamine and ammonia concentrations can be seen in figure 7.3, both 
in agreement with the experimental data from the two cultures. There is a discrepancy 
between the model predictions and the data in the case of the glutamine profile in the 
second batch culture, which could be attributed to a variation in the initial concentration 
of the amino acid, even though the two runs were thought to be identical. The simulation 
results for glutamine exactly match the data in the early hours of the culture, but predict 
that the final concentration is reached at approximately 70 hours, which is earlier than 
in the in vitro experiments. This also leads to the quicker accumulation of ammonia 
predicted by the model. The final concentrations of both glutamine and ammonia are 
correctly determined by the model. 
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Figure 7.3: Comparison of model predictions to experimental data for glutamine and 
ammonia from two batch HEK-293 cultures. 
In the following two figures, 7.4 and 7.5, the agreement between the simulation results 
and the experimental data is shown for glucose and lactate concentrations, respectively. 
The model closely tracks the data through the lag and the exponential growth phase, but, 
again, underpredicts glucose and overpredicts lactate between 60 and 100 hours. Despite 
this discrepancy, the model correctly predicts the trend and the final concentrations of 
both glucose and lactate. 
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Figure 7.4: Comparison of model predictions to experimental data for glucose from two 
batch HEK-293 cultures. 
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Figure 7.5: Comparison of model predictions to experimental data for lactate from two 
batch HEK-293 cultures. 
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Figure 7.6: Comparison of model predictions to experimental data for aspartate and ala-
nine from two batch HEK-293 cultures. 
In terms of the other amino acids, figures 7.6 to 7.10 show the good agreement of 
the model predictions with the experimental data for both those consumed and those 
produced. More specifically, figure 7.6 shows that the experimental profiles of aspartate 
and alanine are closely matched by the model simulation results. Aspartate concentration 
is accurately predicted throughout the duration of the culture. Similarly, data for alanine 
concentration are in agreement with simulation results in the lag and early exponential 
growth phases. The model underpredicts alanine build-up at the later stages of the culture, 
but reaches the same final concentration value as the experimental data. 
A
m
in
o  
ac
id
 c
on
ce
nt
ra
tio
n  
(m
M
)  
0 20 	40 	6D 80 100 120 
0.0 
1.4 - 
1.2 - 
A
m
in
o  
ac
id
 c
on
ce
nt
ra
tio
n
  (
m
M
)  
1.0 - 
0.8 - 
0.6 - 
0.4 - 
0.2 
• Proline, batch 1 
■ Proline, batch 2 
Proline model results 
O Vane, batch 2 
O Valine, batch 1 
Valine model results 
• • 
• 
0 0- 	0 
O — — — — —p— — 
• 
7.2. Model simulation results 	 108 
Time (hr) 
Figure 7.7: Comparison of model predictions to experimental data for proline and valine 
from two batch HEK-293 cultures. 
Proline and valine concentrations are also correctly predicted (figure 7.7). In both 
cases, simulation results match experimental observations throughout the culture. The 
model also accurately predicts when the concentrations of the two amino acids reach their 
final values, as well as the final concentrations themselves. Similar agreement was achieved 
for histidine and threonine concentrations (figure 7.8). The profiles of these two consumed 
amino acids are successfully predicted by the proposed model at all stages of the culture. 
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Figure 7.8: Comparison of model predictions to experimental data for histidine and thre-
onine from two batch HEK-293 cultures. 
Methionine and leucine concentrations are also correctly predicted by the proposed 
model (figure 7.9). The simulation results closely track the experimental data from the 
two batch cultures throughout the duration of the cultures. Finally, the model successfully 
simulates the concentrations of serine and arginine as shown in figure 7.10. The profile of 
arginine is accurately predicted at all stages of the culture. The data for serine are closely 
matched by simulation results, but the model expects its concentration to reach its final 
value earlier than experimentally observed, as was the case for the two main nutrients 
(glucose and glutamine). 
2.0 
A
m
in
o
  a
ci
d 
co
nc
en
tr
at
io
n  
(m
M
)  
1.5 
1.0 
0.5 
7.2. Model simulation results 	 110 
2.5 
• Methionine, batch 1 
❑ Methionine, batch 2 
• Methionine model results 
• Leucine, batch 1 
■ Leucine, batch 2 
— — Leudne model results 
■ — — -e — 	— • • 
1-711"---15 • 
n 
0.0 
0 60 
Time (hr) 
29 
	
40 80 
	
100 
	
120 
Figure 7.9: Comparison of model predictions to experimental data for methionine and 
leucine from two batch HEK-293 cultures. 
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Figure 7.10: Comparison of model predictions to experimental data for serine and arginine 
from two batch HEK-293 cultures. 
7.3. Conclusions 	 111 
Overall, the simulation results presented above successfully predict the experimental 
data for cell, nutrient and metabolite concentrations from the two hatch cultures of HEK-
293 cells. Parameter values were also estimated from experimental data for a CHO-IF1Nry 
cell line (experiments performed by Danny F.C. Wong at the Bioprocessing Technology 
Institute, A*STAR, Singapore) in collaboration with Carolyn M. Lam. The resulting 
model predictions are in good agreement with the experimental profiles of the cell popula-
tion and the amino acid, glucose, lactate, and ammonia concentrations (Kontoravdi et al., 
Submitted to Biotechnology and Bioengineering). 
7.3 Conclusions 
An unstructured model for cell growth and death and the metabolism of glucose, gluta-
mine, and another 19 amino acids in mammalian cells was proposed. Model simulation 
results for batch culture conditions were shown to be in good agreement with dynamic 
experimental data for human embryonic kidney cells. The same model structure with 
minor modifications according to the metabolic network of each cell line and with suitable 
adjustments to parameter values can be used for Chinese hamster ovary cells producing 
interferonry cells. To my knowledge, this is one of the first attempts to thoroughly describe 
and successfully simulate amino acid metabolism using unstructured modelling. This ap-
proach paves the way for the creation of a model library for different cell lines and culture 
operating conditions, which can be used, for example, for deciphering biological knowl-
edge through designed experiments or for applying model-based control and optimisation 
techniques. 
Chapter 8 
Concluding Remarks and Future 
Directions 
8.1 Summary of results 
This thesis presented an integrated modelling/experimental framework for the system-
atic development of predictive mathematical models of animal cell cultures applicable to 
both batch and fed-batch operation modes. First, the relevant biological background was 
discussed, followed by a review of existing literature with respect to both experimental 
findings and modelling approaches. The proposed model structure was then presented, 
which describes cell growth and death, cell metabolism, MAb synthesis and secretion, 
and protein glycosylation in a hybrid, structured/unstructured, manner. Its simulation 
results were shown to be in good agreement with batch culture data for a MAb-producing 
hybridoma cell line, thus validating the applicability of the model structure to the exper-
imental system under investigation. 
Following that, a critical review of available methods for parametric analysis was car-
ried out pointing out the Sobol' method for global sensitivity analysis as one of the most 
powerful tools for identifying sensitive model parameters. This was applied to the proposed 
model highlighting 8 out of a total of 30 model parameters that are most significant with 
respect to MAb concentration. A further qualitative one-at-a-time screening of model 
parameters helped identify the final set of seven parameters that necessitated accurate 
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estimation based on the experimental measurements that were available in our labora-
tory. Optimal experimental design tools were then employed to design information-rich 
fed-batch experiments for model validation and parameter estimation. The resulting agree-
ment of model simulation results and experimental data was deemed satisfactory after one 
iteration (design - experiment - validation and estimation). The confidence intervals of the 
estimated parameters were also found to be acceptable, with the 95% confidence intervals 
lying within +10% of the final values. Finally, the predictive capability of the model was 
checked by comparison to an independent set of fed-batch culture data. Results showed 
that the proposed model correctly predicts the process variables monitored during the 
experiments. 
In a further study, an unstructured model of cell growth and death and the metabolism 
of glucose and 19 amino acids was developed for the human embryonic kidney 293 cell line. 
This is one of the first attempts to capture the dynamics of amino acid metabolism using 
unstructured modelling, but based on known intracellular pathways and empirical knowl-
edge. The model simulation results are in good agreement with batch culture data. Similar 
results were achieved for an interferon'y-producing Chinese hamster ovaries cell line using 
a comparable model structure. 
8.2 Main conclusions 
A number of conclusions can be drawn from the above findings: 
1. Simple mathematical models can successfully describe key cell culture variables, such 
as cell and nutrient concentrations, under batch and fed-batch conditions, and are, 
to some extent, suitable for in silico experimentation. Predictive models can only be 
the result of a systematic approach that combines modelling and experimentation 
at each stage of the model development process. 
2. Once validated, the integrated dynamic model for protein glycosylation will enable 
us to monitor product quality. Process optimisation can therefore be performed with 
the dual objective of maximising production and ensuring glycosylation consistency. 
3. Thanks to their computational tractability, such model structures can form an ex- 
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cellent basis for process systems applications within non-extreme culture conditions. 
4. The use of global sensitivity analysis can significantly reduce the size of the parameter 
set to be estimated from experimental data, therefore decreasing the number of 
experiments required for model validation purposes. 
5. The application of optimal experimental design helps avoid unnecessary or uninfor-
mative experimentation. Designed experiments generate information-rich data thus 
expediting the model validation process. 
6. Model-based tools such as global sensitivity analysis and optimal experimental design 
are applicable to biological systems, despite the limitations posed by incomplete 
knowledge of the underlying mechanisms. 
7. The fact that similar structures can describe the behaviours of inherently different 
cell lines implies that modelling information is, to some extent, transferable across 
mammalian cell culture systems. This paves the way for the creation of a model 
library for different cell lines and culture operating conditions. 
8. Overall, the framework presented and validated in this thesis proposes a well-defined 
step-by-step methodology for building predictive models of cell culture processes at 
a minimum experimental cost, while avoiding trial-and-error practices. This system-
atic combination of modelling and experimentation through process systems engi-
neering tools can, in the future, guide process development in the biopharmaceutical 
industry with an aim to reduce the time required for a product to reach the market. 
8.3 Recommendations for future work 
Based on the results and conclusions of this thesis the following suggestions can be made 
for future research directions. 
8.3.1 Model development 
Model enhancement The model presented here is a simple representation of the actual 
system. Its fidelity can be substantially improved through the incorporation of existing 
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biological knowledge in a manner that will not compromise its computational tractabil-
ity. Interesting additions would be that of cell cycle or a more structured representation 
of cell metabolism. The cells' position on the cell cycle has been known to affect their 
productivity. Incorporation of expressions for the cell cycle could therefore prove useful 
for increasing MAb titers, particularly since a relevant unstructured model can be readily 
validated with flow cytometry data. The results for the predictive fed-batch culture fur-
ther stress the necessity of including the cell cycle in the model, as slower growth rates 
appear to result in higher MAb production (see section 6.2). The inclusion of this phe-
nomenon, which is not fully captured by the model, would significantly enhance model 
fidelity. Moreover, this work has demonstrated that cell metabolism is closely linked with 
cell growth and death, MAb production and protein glycosylation. The incorporation 
of detailed expressions for this cellular function, including amino acid metabolism, could 
provide a more accurate modelling framework. 
Extension of global sensitivity analysis The application of global sensitivity analysis 
presented here was limited to MAb concentration as the model output. However, as the 
experimental design and parameter estimation processes clearly showed, a more thorough 
investigation is necessary before concluding which parameters are the most significant. 
For this reason, an extended application of parameter sensitivity analysis to all measured 
variables is proposed, so that the full map of sensitivities and interactions is obtained. 
In this way, we can identify which parameters to estimate from which measurements, 
essentially performing an alternative (numerical) identifiability analysis. 
Development of model library The work carried out on amino acid metabolism has 
demonstrated that a single model structure with minor modifications according to the 
metabolic network of each cell line and with suitable adjustments to parameter values 
can be used for HEK-293 and CHO-IFN-y cells. Moreover, the mathematical model of 
hybridoma cell cultures was based on two previous studies on different cell lines. This 
indicates that there are similarities between different hybridoma cells and that the same 
kinetics are applicable. The aforementioned results pave the way for the creation of a 
model library for different cell lines and culture operating conditions, which can be used, 
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for example, for deciphering biological knowledge through designed experiments or for ap-
plying model-based control and optimisation techniques. Such a library can be constantly 
updated, with models modified or enriched as more information becomes available. Most 
importantly, a model library for commonly used cell lines can, in theory, expedite process 
development, with part of the cell line screening and the optimisation performed in silico. 
8.3.2 Experimental investigations 
Examination of extreme process conditions In the experimental part of this thesis, 
there was limited variation in initial nutrient concentrations in order to avoid starvation 
conditions, which can lead to substantially different metabolic behaviours. However, fed-
batch cultures under starvation conditions are common industrial practice and should, 
therefore, be more thoroughly examined both experimentally and in silico. Even though 
models capturing the multiplicity of steady-states that is possible in continuous cell cul-
tures exist, little progress has been made on describing the dynamics of such phenomena 
in fed-batch cultures. Further experimental analysis can help define the boundary nutri-
ent concentrations and the kinetics applicable to each metabolic regime. This information 
can then help develop a set of mathematical expressions for cell metabolism along with 
their range of validity, shedding some light on the biology and guiding the optimisation of 
process conditions. 
Product quality At this stage, a substantial amount of biological information and ex-
perimental data is required before product quality can be monitored. First, a full map 
of oligosaccharides of a functional and a non-functional protein, be it a MAb or another 
protein of interest, needs to be obtained. The connection between process conditions and 
glycosylation also needs to be elucidated, in order to eventually enable us to control prod-
uct quality or to at least ensure consistency of oligosaccharide content, which is essential 
for obtaining FDA approval. 
8.3. Recommendations for future work 	 117 
8.3.3 Model-based applications 
Hypothesis testing Predictive models of animal cell cultures can aid in reducing in 
vitro experimentation by performing part of the experiments in silico, especially during 
the initial stages of cell line screening, or by guiding process optimisation when switch-
ing from batch to fed-batch culture conditions. Their use in conjunction with optimal 
experimental design can further be used to elucidate the underlying biological principles. 
More specifically, experimental design tools can be employed to validate or disprove model 
structures supporting a certain hypothesis (experimental design for hypothesis testing). 
Such targeted experimentation can, therefore, help further our understanding of cellular 
mechanism. An example of where this approach would be applicable is the aforementioned 
dependence of protein productivity on cell cycle position, which has generated conflicting 
reports and appears to be a cell line-dependent phenomenon. 
Process control & optimisation One of the obvious applications of predictive mathe-
matical models is that of model-based control and optimisation. At the moment, industrial 
operation of cell culture processes is mainly empirical. However, model-based control can 
be used to keep culture variables within desired limits, eliminating the need for frequent 
sampling and operator intervention. Dynamic optimisation techniques can be used to 
identify worst- and best-case scenarios for fed-batch cultures, the former to be avoided 
and the latter to be further refined experimentally so as to reach truly optimal operating 
conditions. 
Process scale-up Experimentally, it would be useful to examine the cell dynamics of 
larger cultures and to identify possible differences from the behaviours presented in this 
work with 200m1 flask. Any variations would lead to the determination of a separate set 
of values for model parameters for each configuration and scale examined. This follows, 
of course, the transition from a bench-top experiment to pilot plant investigation and, 
finally, to industrial-scale production of biologics, and will allow us to track how control 
and optimisation strategies may need to change depending on the size of the culture. 
Another important consideration in the case of modelling large-scale cultures would be 
heterogeneities in the medium concentration and the resulting formation of faster or slower 
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growing clusters of cells. A possible way of identifying regions of varying medium concen-
tration would be to rebuild the reactor configuration in a computational fluid dynamics 
tool, such as CFX, and thus to model the mass transport phenomena. 
Process scheduling Model-based tools can also be used for the scheduling of the entire 
industrial production process. The rate limiting step of the latter appears to be the 
production at the bioreactor level, which greatly affects subsequent operations until the 
MAbs are ready to use clinically or in the laboratory. Since it is possible to develop 
reliable models of this operation, it is also feasible to predict with some accuracy its 
duration. This can significantly aid the scheduling of the purification process that follows, 
allowing industry to take full advantage of existing equipment. Such an application will 
become increasingly important as more antibodies and other biologics pass clinical trials 
and reach the stage of industrial production. 
Towards a fully automated lab Ultimately, it would be desirable to have a fully 
automated system, where the experimental set-up is connected to gPROMS. In this way, 
experimental data will be fed to the model, model parameters will be estimated and a 
new optimisation strategy will be developed and conveyed to the control unit of the biore-
actor. At the moment there are certain limitations to the realisation of such a real-time 
closed-loop system. First and foremost, several molecular biology techniques can only be 
performed manually off-line, with key data, such as monoclonal antibody concentrations, 
becoming available many hours after acquiring the sample from the culture. Second, soft-
ware needs to be developed that allows the equipment involved (bioreactor control unit, 
bioanalyser, etc.) to communicate with gPROMS. The latter is by far the most suitable 
tool for such an application, as it has in-built functions for performing model simulation, 
parameter estimation, experiment design, and optimisation operations. Only once such 
a closed-loop real-time system is in place, can we apply model predictive control to cell 
culture systems. 
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